Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
70000,,,5176039,[],CHEMBL1666922,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70001,,,5176040,[],CHEMBL1666923,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70002,,,5176041,[],CHEMBL1666925,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70003,,,5176065,[],CHEMBL1666919,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
70004,,,5176067,[],CHEMBL1666921,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
70005,,,5176230,[],CHEMBL1665482,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 0.125 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,44.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,44.4
70006,,,5176231,[],CHEMBL1665496,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 0.125 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,54.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,54.3
70007,,,5176255,[],CHEMBL1665497,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 0.25 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,90.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,90.2
70008,,,5176256,[],CHEMBL1665481,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 0.25 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,92.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,92.6
70009,,,5176262,[],CHEMBL1665477,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70010,,,5176267,[],CHEMBL1665487,Antimicrobial activity against heterogeneous vancomycin-susceptible Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70011,,,5176271,[],CHEMBL1665491,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 0.5 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70012,,,5176273,[],CHEMBL1665492,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70013,,,5176275,[],CHEMBL1665493,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 2 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70014,,,5176279,[],CHEMBL1665494,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 4 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70015,,,5176284,[],CHEMBL1665495,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 16 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70016,,,5176287,[],CHEMBL1665498,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 0.5 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70017,,,5176289,[],CHEMBL1665499,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70018,,,5177299,[],CHEMBL1665500,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 2 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70019,,,5177304,[],CHEMBL1665501,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 4 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70020,,,5177309,[],CHEMBL1665529,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 16 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1321865,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
70021,,,5177393,[],CHEMBL1665471,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.032
70022,,,5177394,[],CHEMBL1665483,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321865,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.032
70023,,,5177910,[],CHEMBL1659089,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70024,,,5177917,[],CHEMBL1659090,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 144 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70025,,,5177922,[],CHEMBL1659091,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 156 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322813,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
70026,,,5177929,[],CHEMBL1659092,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 147 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70027,,,5177936,[],CHEMBL1659093,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 56 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322813,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
70028,,,5177943,[],CHEMBL1659094,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 152 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
70029,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5177944,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.25'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1659095,"Cmax in BALB/c mouse infected with Staphylococcus aureus at 6.25 mg/kg, sc administered as single dose",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1322813,=,1,1,=,,Cmax,nM,,2680.74,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,1.57
70030,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5177945,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1659096,"Cmax in BALB/c mouse infected with Staphylococcus aureus at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1322813,=,1,1,=,,Cmax,nM,,5276.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,3.09
70031,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5177946,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1659097,"Cmax in BALB/c mouse infected with Staphylococcus aureus at 25 mg/kg, sc administered as single dose",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1322813,=,1,1,=,,Cmax,nM,,10227.78,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,5.99
70032,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5177947,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1659098,"Cmax in BALB/c mouse infected with Staphylococcus aureus at 50 mg/kg, sc administered as single dose",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1322813,=,1,1,=,,Cmax,nM,,26978.11,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,15.8
70033,,,5177948,[],CHEMBL1659099,"Tmax in BALB/c mouse infected with Staphylococcus aureus at 6.25 mg/kg, sc administered as single dose",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,Tmax,hr,,0.34,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,0.34
70034,,,5177949,[],CHEMBL1659100,"Tmax in BALB/c mouse infected with Staphylococcus aureus at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,Tmax,hr,,0.27,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,0.27
70035,,,5177950,[],CHEMBL1659101,"Tmax in BALB/c mouse infected with Staphylococcus aureus at 25 mg/kg, sc administered as single dose",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,Tmax,hr,,0.74,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,0.74
70036,,,5177951,[],CHEMBL1659102,"Tmax in BALB/c mouse infected with Staphylococcus aureus at 50 mg/kg, sc administered as single dose",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,Tmax,hr,,0.35,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,0.35
70037,,,5177952,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.25'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1659103,"AUC (0 to 24 hrs) in BALB/c mouse infected with Staphylococcus aureus at 6.25 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,9980.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/L,,,9.98
70038,,,5177953,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1659104,"AUC (0 to 24 hrs) in BALB/c mouse infected with Staphylococcus aureus at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,16520.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/L,,,16.52
70039,,,5177954,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1659105,"AUC (0 to 24 hrs) in BALB/c mouse infected with Staphylococcus aureus at 25 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,37490.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/L,,,37.49
70040,,,5177955,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1659106,"AUC (0 to 24 hrs) in BALB/c mouse infected with Staphylococcus aureus at 50 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,72520.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/L,,,72.52
70041,,,5177956,[],CHEMBL1659107,"Half life in BALB/c mouse infected with Staphylococcus aureus at 6.25 mg/kg, sc administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,T1/2,hr,,12.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,12.4
70042,,,5177957,[],CHEMBL1659108,"Half life in BALB/c mouse infected with Staphylococcus aureus at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,T1/2,hr,,7.13,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,7.13
70043,,,5177958,[],CHEMBL1659109,"Half life in BALB/c mouse infected with Staphylococcus aureus at 25 mg/kg, sc administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,T1/2,hr,,12.43,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,12.43
70044,,,5177959,[],CHEMBL1659110,"Half life in BALB/c mouse infected with Staphylococcus aureus at 50 mg/kg, sc administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1322813,=,1,1,=,,T1/2,hr,,11.52,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,11.52
70045,,,5177960,[],CHEMBL1659111,"Volume of distribution in BALB/c mouse infected with Staphylococcus aureus at 6.25 mg/kg, sc administered as single dose",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,Vd,L.kg-1,,3.44,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vd,L/Kg,UO_0000197,,3.44
70046,,,5177961,[],CHEMBL1659112,"Volume of distribution in BALB/c mouse infected with Staphylococcus aureus at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,Vd,L.kg-1,,3.62,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vd,L/Kg,UO_0000197,,3.62
70047,,,5177962,[],CHEMBL1659113,"Volume of distribution in BALB/c mouse infected with Staphylococcus aureus at 25 mg/kg, sc administered as single dose",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,Vd,L.kg-1,,2.77,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vd,L/Kg,UO_0000197,,2.77
70048,,,5177963,[],CHEMBL1659114,"Volume of distribution in BALB/c mouse infected with Staphylococcus aureus at 50 mg/kg, sc administered as single dose",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,Vd,L.kg-1,,2.62,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vd,L/Kg,UO_0000197,,2.62
70049,,,5177964,[],CHEMBL1659115,"Protein binding in Staphylococcus aureus-infected BALB/c mouse serum at 6.25 mg/kg, sc administered as single dose",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1322813,=,1,1,=,,PPB,%,,85.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PB,%,UO_0000187,,85.0
70050,,,5177965,[],CHEMBL1659116,"Protein binding in Staphylococcus aureus-infected BALB/c mouse serum at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1322813,=,1,1,=,,PPB,%,,87.2,CHEMBL613590,Mus musculus,Serum,10090.0,,,PB,%,UO_0000187,,87.2
70051,,,5177966,[],CHEMBL1659222,"Protein binding in Staphylococcus aureus-infected BALB/c mouse serum at 25 mg/kg, sc administered as single dose",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1322813,=,1,1,=,,PPB,%,,93.7,CHEMBL613590,Mus musculus,Serum,10090.0,,,PB,%,UO_0000187,,93.7
70052,,,5177967,[],CHEMBL1659223,"Protein binding in Staphylococcus aureus-infected BALB/c mouse serum at 50 mg/kg, sc administered as single dose",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1322813,=,1,1,=,,PPB,%,,95.9,CHEMBL613590,Mus musculus,Serum,10090.0,,,PB,%,UO_0000187,,95.9
70053,,,5177968,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '8.0'}]",CHEMBL1659224,"AUC (0 to 8 hrs) in Staphylococcus aureus-infected BALB/c mouse epithelial lining fluid at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,11000.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,11.0
70054,,,5177969,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '8.0'}]",CHEMBL1659225,"AUC (0 to 8 hrs) in Staphylococcus aureus-infected BALB/c mouse epithelial lining fluid at 25 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,20400.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,20.4
70055,,,5177970,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '8.0'}]",CHEMBL1659226,"AUC (0 to 8 hrs) in Staphylococcus aureus-infected BALB/c mouse epithelial lining fluid at 50 mg/kg, sc administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,1,=,,AUC,ng.hr.mL-1,,41900.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,41.9
70056,,,5177971,[],CHEMBL1659227,"Ratio of fAUC (0 to 8 hrs) in epithelial lining fluid to plasma of Staphylococcus aureus-infected BALB/c mouse at 12.5 mg/kg, sc administered as single dose",A,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,Ratio,,,7.02,CHEMBL612558,,ADMET,,,,Ratio,,,,7.02
70057,,,5177972,[],CHEMBL1659228,"Ratio of fAUC (0 to 8 hrs) in epithelial lining fluid to plasma of Staphylococcus aureus-infected BALB/c mouse at 25 mg/kg, sc administered as single dose",A,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,Ratio,,,15.11,CHEMBL612558,,ADMET,,,,Ratio,,,,15.11
70058,,,5177973,[],CHEMBL1659229,"Ratio of fAUC (0 to 8 hrs) in epithelial lining fluid to plasma of Staphylococcus aureus-infected BALB/c mouse at 50 mg/kg, sc administered as single dose",A,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,Ratio,,,23.95,CHEMBL612558,,ADMET,,,,Ratio,,,,23.95
70059,,,5177974,[],CHEMBL1659230,Ratio of fAUC to MIC in methicillin-susceptible Staphylococcus aureus ATCC 29213-infected BALB/c mouse at 80% maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.68,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.68
70060,,,5177975,[],CHEMBL1659231,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 144-infected BALB/c mouse at 80% maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.64,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.64
70061,,,5177976,[],CHEMBL1659232,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 156-infected BALB/c mouse at 80% maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,5.22,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,5.22
70062,,,5177977,[],CHEMBL1659233,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 147-infected BALB/c mouse at 80% maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,3.12,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,3.12
70063,,,5177978,[],CHEMBL1659234,Ratio of fAUC to MIC in hospital-acquired methicillin-resistant Staphylococcus aureus 56-infected BALB/c mouse at 80% maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.11,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.11
70064,,,5177979,[],CHEMBL1659235,Ratio of fAUC to MIC in hospital-acquired methicillin-resistant Staphylococcus aureus 152-infected BALB/c mouse at 80% maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.48,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.48
70065,,,5177980,[],CHEMBL1659236,Ratio of fAUC to MIC in methicillin-susceptible Staphylococcus aureus ATCC 29213-infected BALB/c mouse at 505 maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.33,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.33
70066,,,5177981,[],CHEMBL1659237,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 144-infected BALB/c mouse at 505 maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.29,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.29
70067,,,5177982,[],CHEMBL1659238,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 156-infected BALB/c mouse at 505 maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,3.91,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,3.91
70068,,,5177983,[],CHEMBL1659239,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 147-infected BALB/c mouse at 505 maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,0.69,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,0.69
70069,,,5177984,[],CHEMBL1659240,Ratio of fAUC to MIC in hospital-acquired methicillin-resistant Staphylococcus aureus 56-infected BALB/c mouse at 505 maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,0.38,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,0.38
70070,,,5177985,[],CHEMBL1659241,Ratio of fAUC to MIC in hospital-acquired methicillin-resistant Staphylococcus aureus 152-infected BALB/c mouse at 505 maximal effective concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,1.43,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,1.43
70071,,,5177986,[],CHEMBL1659242,Ratio of fAUC to MIC in methicillin-susceptible Staphylococcus aureus ATCC 29213-infected BALB/c mouse at bacteriostatic concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.38,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.38
70072,,,5177987,[],CHEMBL1659243,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 144-infected BALB/c mouse at bacteriostatic concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,2.17,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,2.17
70073,,,5177988,[],CHEMBL1659244,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 156-infected BALB/c mouse at bacteriostatic concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,4.18,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,4.18
70074,,,5177989,[],CHEMBL1659892,Ratio of fAUC to MIC in community-acquired methicillin-resistant Staphylococcus aureus 147-infected BALB/c mouse at bacteriostatic concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,0.41,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,0.41
70075,,,5177990,[],CHEMBL1659893,Ratio of fAUC to MIC in hospital-acquired methicillin-resistant Staphylococcus aureus 56-infected BALB/c mouse at bacteriostatic concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,0.43,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,0.43
70076,,,5177991,[],CHEMBL1659894,Ratio of fAUC to MIC in hospital-acquired methicillin-resistant Staphylococcus aureus 152-infected BALB/c mouse at bacteriostatic concentration,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1322813,=,1,0,=,,fAUC/MIC,,,1.51,CHEMBL612545,,Unchecked,,,,fAUC/MIC,,,,1.51
70077,,,5178213,[],CHEMBL1658210,"Antimicrobial activity against Klebsiella pneumoniae isolate 048 expressing beta-lactamase KPC-2, DHA-1, qnrB4 and armA by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649310,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323716,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.38
70078,,,5178214,[],CHEMBL1658211,"Antimicrobial activity against Escherichia coli isolate CKP048 transconjugant harboring beta-lactamase KPC-2, DHA-1, qnrB4 and armA by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649310,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323716,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70079,,,5178215,[],CHEMBL1658212,"Antimicrobial activity against lacZ-negative, Nalidixic acid-, rifampicin-resistant Escherichia coli EC600 by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649310,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323716,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70080,,,5180548,[],CHEMBL1660180,Antibacterial activity against Enterobacter hormaechei isolate UCN62,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649266,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322852,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL615043,Enterobacter hormaechei,Enterobacter hormaechei,158836.0,,,MIC,ug ml-1,UO_0000274,,2.0
70081,,,5180554,[],CHEMBL1660185,Antibacterial activity against Enterobacter hormaechei isolate UCN63 after 3 weeks of treatment,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649266,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322852,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL615043,Enterobacter hormaechei,Enterobacter hormaechei,158836.0,,,MIC,ug ml-1,UO_0000274,,4.0
70082,,,5180555,[],CHEMBL1660184,Antibacterial activity against Enterobacter cloacae UCN62 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649266,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322852,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
70083,,,5180556,[],CHEMBL1660183,Antibacterial activity against Enterobacter cloacae UCN62 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649266,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322852,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
70084,,,5180557,[],CHEMBL1660182,Antibacterial activity against Enterobacter cloacae UCN63 by Etest after 3 weeks of treatment,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649266,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322852,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,3.0
70085,,,5180558,[],CHEMBL1660181,Antibacterial activity against Enterobacter cloacae UCN63 by broth microdilution method after 3 weeks of treatment,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649266,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322852,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,4.0
70086,,,5181627,[],CHEMBL1654889,Antimalarial activity against Plasmodium falciparum isolates assessed as parasite growth inhibition after 72 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649214,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,6.16,0,http://www.openphacts.org/units/Nanomolar,1321989,=,1,1,=,,IC50,nM,,699.11,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,nM,UO_0000065,,699.11
70087,,,5181634,[],CHEMBL1654889,Antimalarial activity against Plasmodium falciparum isolates assessed as parasite growth inhibition after 72 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay,F,,,BAO_0002144,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649214,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1321989,=,1,1,=,,IC90,nM,,5905.83,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC90,nM,UO_0000065,,5905.83
70088,,,5181641,[],CHEMBL1654889,Antimalarial activity against Plasmodium falciparum isolates assessed as parasite growth inhibition after 72 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649214,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1321989,=,1,1,=,,IC99,nM,,12416.87,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC99,nM,UO_0000065,,12416.87
70089,,,5181649,[],CHEMBL1654890,Ratio of IC50 for Plasmodium falciparum isolates after 72 hrs to IC50 for Plasmodium falciparum isolates after 24 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649214,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1321989,=,1,0,=,,Ratio IC50,,,49.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Ratio IC50,,,,49.0
70090,,,5181783,[],CHEMBL1653346,Antimicrobial activity against Klebsiella pneumoniae isolate 2641/08 obtained from urine of patient with ischemic cardiomyopathy and several comorbidities by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649217,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322018,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,3.0
70091,,,5181784,[],CHEMBL1653347,Antimicrobial activity against rifampicin-resistant Escherichia coli A15 transconjugant expressing beta-lactamase KPC-2/TEM-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649217,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322018,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
70092,,,5181785,[],CHEMBL1653348,Antimicrobial activity against rifampicin-resistant Escherichia coli A15 transconjugant expressing beta-lactamase SHV-12 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649217,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322018,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
70093,,,5181786,[],CHEMBL1653349,Antimicrobial activity against rifampicin-resistant Escherichia coli A15 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649217,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322018,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
70094,,,5183182,[],CHEMBL1654493,Antimicrobial activity against Klebsiella pneumoniae PFGE clone A expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
70095,,,5183183,[],CHEMBL1654494,Antimicrobial activity against Klebsiella pneumoniae PFGE clone B expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70096,,,5183184,[],CHEMBL1654495,Antimicrobial activity against Klebsiella pneumoniae PFGE clone C expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70097,,,5183185,[],CHEMBL1655110,Antimicrobial activity against Klebsiella pneumoniae PFGE clone D expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70098,,,5183186,[],CHEMBL1655111,Antimicrobial activity against Klebsiella pneumoniae PFGE clone E expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70099,,,5183187,[],CHEMBL1655112,Antimicrobial activity against Klebsiella pneumoniae PFGE clone F expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.38
70100,,,5183188,[],CHEMBL1655113,Antimicrobial activity against Klebsiella oxytoca expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,2.0
70101,,,5183189,[],CHEMBL1655114,Antimicrobial activity against Enterobacter cloacae expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322314,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
70102,,,5184271,[],CHEMBL1653771,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate VA-566/00 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327146,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70103,,,5184272,[],CHEMBL1653772,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate N50 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327146,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,1.0
70104,,,5184273,[],CHEMBL1653773,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate RUH134 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327146,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,1.0
70105,,,5184274,[],CHEMBL1653774,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate RUH134 harboring plasmid ABVA01 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327146,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,1.0
70106,,Not Active,5210639,[],CHEMBL1677625,Antimicrobial activity against Staphylococcus isolates biofilms assessed as decrease in bacterial load at 1 to 25 mg/litre at ambient temperature of 30 to 45 degC after 24 hrs relative to baseline,F,,,BAO_0000375,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,,1,0,,,Activity,,,,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Activity,,,,
70107,,,5210662,[],CHEMBL1677514,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 1 mg/litre at ambient temperature of 35 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,0.98,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,0.98
70108,,,5210663,[],CHEMBL1677515,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 5 mg/litre at ambient temperature of 35 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,0.99,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,0.99
70109,,,5210664,[],CHEMBL1677610,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 25 mg/litre at ambient temperature of 35 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,1.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,1.12
70110,,,5210665,[],CHEMBL1677611,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 1 mg/litre at ambient temperature of 40 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,1.31,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,1.31
70111,,,5210666,[],CHEMBL1677612,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 5 mg/litre at ambient temperature of 40 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,1.1,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,1.1
70112,,,5210667,[],CHEMBL1677613,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 25 mg/litre at ambient temperature of 40 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,0.83,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,0.83
70113,,,5210668,[],CHEMBL1677614,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 1 mg/litre at ambient temperature of 45 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,0.93,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,0.93
70114,,,5210669,[],CHEMBL1677615,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 5 mg/litre at ambient temperature of 45 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,0.86,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,0.86
70115,,,5210670,[],CHEMBL1677616,Antimicrobial activity against Staphylococcus isolates biofilms assessed as change in optical density ratio of biofilms at 25 mg/litre at ambient temperature of 45 degC after 24 hrs relative to baseline,F,,,BAO_0000193,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,=,1,0,=,,Ratio,,,1.32,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Ratio,,,,1.32
70116,,Not Active,5210673,[],CHEMBL1677617,Antimicrobial activity against Staphylococcus isolates biofilms assessed as decrease in bacterial load at 100 mg/litre at ambient temperature of 35 degC after 24 hrs relative to baseline,F,,,BAO_0000375,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332594,,1,0,,,Activity,,,,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Activity,,,,
70117,,,5210689,[],CHEMBL1677496,Antimicrobial activity against Staphylococcus aureus isolated from human prosthetic joint infection site by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.125
70118,,,5210690,[],CHEMBL1677497,Antimicrobial activity against coagulase-negative Staphylococcus isolated from human prosthetic joint infection site by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,6e-05,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug/L,UO_0000274,,0.06
70119,,,5210691,[],CHEMBL1677495,Antimicrobial activity against Staphylococcus aureus isolated from human preoperative skin by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,6e-05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.06
70120,,,5210692,[],CHEMBL1677494,Antimicrobial activity against coagulase-negative Staphylococcus isolated from human preoperative skin by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,3e-05,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug/L,UO_0000274,,0.03
70121,,,5210693,[],CHEMBL1677493,Antimicrobial activity against Staphylococcus epidermidis isolate KO8 isolated from healthy human skin by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug/L,UO_0000274,,0.125
70122,,,5210694,[],CHEMBL1677492,Antimicrobial activity against Staphylococcus aureus ATCC 29213 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,6e-05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.06
70123,,,5210695,[],CHEMBL1677490,Antimicrobial activity against Staphylococcus epidermidis DSM3269 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,0.0005,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug/L,UO_0000274,,0.5
70124,,,5210712,[],CHEMBL1677491,Antimicrobial activity against Staphylococcus aureus ATCC 29213 administered as powder at 45 degC after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,1.0
70125,,,5210717,[],CHEMBL1677498,Antimicrobial activity against Staphylococcus epidermidis isolate OR1 treated in solution at 45 degC after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332594,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug/L,UO_0000274,,2.0
70126,,,5210776,[],CHEMBL1676046,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB018 with PFGE subgroup G containing carbapenemase OXA-58 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,2.0
70127,,,5210782,[],CHEMBL1676047,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB039 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,2.0
70128,,,5210788,[],CHEMBL1676048,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB095 with PFGE subgroup E containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,2.0
70129,,,5210794,[],CHEMBL1676049,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB110 with PFGE subgroup C containing carbapenemase OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,2.0
70130,,,5210800,[],CHEMBL1676050,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB127 with PFGE subgroup I containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70131,,,5210806,[],CHEMBL1676051,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB166 with PFGE subgroup A3 containing carbapenemase OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70132,,,5210812,[],CHEMBL1676052,Antibacterial activity against intI1-negative tigecycline-intermediate Acinetobacter baumannii AB098 with PFGE subgroup F containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,6.0
70133,,,5210818,[],CHEMBL1676053,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB099 with PFGE subgroup H containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,6.0
70134,,,5210824,[],CHEMBL1676054,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB106 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70135,,,5210830,[],CHEMBL1676055,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB113 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70136,,,5210836,[],CHEMBL1676056,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB118 with PFGE subgroup B2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70137,,,5210842,[],CHEMBL1676057,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB125 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70138,,,5210848,[],CHEMBL1676058,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB134 with PFGE subgroup A2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70139,,,5210854,[],CHEMBL1676059,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB168 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70140,,,5210860,[],CHEMBL1676060,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB173 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70141,,,5210866,[],CHEMBL1676061,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB097 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,12.0
70142,,,5210872,[],CHEMBL1676062,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB096 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,16.0
70143,,,5210878,[],CHEMBL1676063,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB018 with PFGE subgroup G containing carbapenemase OXA-58 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,2.0
70144,,,5210879,[],CHEMBL1676064,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB039 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70145,,,5210880,[],CHEMBL1678382,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB095 with PFGE subgroup E containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,3.0
70146,,,5210881,[],CHEMBL1678383,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB110 with PFGE subgroup C containing carbapenemase OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70147,,,5210882,[],CHEMBL1678384,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB127 with PFGE subgroup I containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70148,,,5210883,[],CHEMBL1678385,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB166 with PFGE subgroup A3 containing carbapenemase OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70149,,,5210884,[],CHEMBL1678386,Antibacterial activity against intI1-negative tigecycline-intermediate Acinetobacter baumannii AB098 with PFGE subgroup F containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70150,,,5210885,[],CHEMBL1678387,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB099 with PFGE subgroup H containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70151,,,5210886,[],CHEMBL1678388,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB106 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,6.0
70152,,,5210887,[],CHEMBL1678389,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB113 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70153,,,5210888,[],CHEMBL1678390,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB118 with PFGE subgroup B2 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,6.0
70154,,,5210889,[],CHEMBL1678391,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB125 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70155,,,5210890,[],CHEMBL1678392,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB134 with PFGE subgroup A2 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,3.0
70156,,,5210891,[],CHEMBL1678393,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB168 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70157,,,5210892,[],CHEMBL1678394,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB173 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70158,,,5210893,[],CHEMBL1678395,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB097 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
70159,,,5210894,[],CHEMBL1678396,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB096 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest in presence of 64 mg/liter 1-(1-naphthylmethyl)-piperazine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
70160,,,5210895,[],CHEMBL1678397,Antibacterial activity against Multidrug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,mg/L,UO_0000274,,2.0
70161,,,5210896,[],CHEMBL1678398,Antibacterial activity against Multidrug-resistant Acinetobacter baumannii clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,1.0
70162,,,5210897,[],CHEMBL1678399,Steady state drug concentration in human serum,A,,,BAO_0000179,BAO_0000366,cell-free format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332603,=,1,0,=,,Css,mg/L,,0.63,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Css,mg/L,,,0.63
70163,,,5210898,[],CHEMBL1678397,Antibacterial activity against Multidrug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,mg/L,UO_0000274,,4.0
70164,,,5210899,[],CHEMBL1678398,Antibacterial activity against Multidrug-resistant Acinetobacter baumannii clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,mg/L,UO_0000274,,16.0
70165,,,5210900,[],CHEMBL1678398,Antibacterial activity against Multidrug-resistant Acinetobacter baumannii clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332603,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,mg/L,UO_0000274,,32.0
70166,,,5211076,[],CHEMBL1680763,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 38 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.09,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.09
70167,,,5211079,[],CHEMBL1680600,"Antimicrobial activity against Acinetobacter baumannii lambda clonal group isolate 27 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.19
70168,,,5211085,[],CHEMBL1680761,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 37 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
70169,,,5211086,[],CHEMBL1680765,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 39 expressing ampC, ompA, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
70170,,,5211095,[],CHEMBL1678991,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 6 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
70171,,,5211096,[],CHEMBL1679713,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 7 expressing ampC, ompA, adeB, adeM, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
70172,,,5211097,[],CHEMBL1680767,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii unique clonal group isolate 40 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
70173,,,5211099,[],CHEMBL1678981,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 1 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70174,,,5211100,[],CHEMBL1679719,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 10 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70175,,,5211101,[],CHEMBL1679721,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 11 expressing ompA, adeB, adeM, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70176,,,5211102,[],CHEMBL1679723,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 12 expressing ompA, adeB, adeM, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70177,,,5211114,[],CHEMBL1679869,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 21 expressing ampC, ompA, adeB, adeM, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
70178,,,5211115,[],CHEMBL1679873,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 23 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, aphA6 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
70179,,,5211120,[],CHEMBL1679715,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 8 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
70180,,,5211121,[],CHEMBL1679871,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 22 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
70181,,,5211122,[],CHEMBL1680747,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 30 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
70182,,,5211135,[],CHEMBL1679717,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 9 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
70183,,,5211136,[],CHEMBL1679863,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 18 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
70184,,,5211219,[],CHEMBL1680602,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 28 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.19
70185,,,5211220,[],CHEMBL1680745,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 29 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.19
70186,,,5211225,[],CHEMBL1680757,"Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 35 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
70187,,,5211226,[],CHEMBL1680759,"Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 36 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
70188,,,5211236,[],CHEMBL1680749,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 31 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70189,,,5211237,[],CHEMBL1680751,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 32 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70190,,,5211238,[],CHEMBL1680753,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 33 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70191,,,5211239,[],CHEMBL1680755,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 34 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70192,,,5211244,[],CHEMBL1679725,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 13 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70193,,,5211245,[],CHEMBL1679727,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 14 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70194,,,5211246,[],CHEMBL1679729,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 15 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70195,,,5211247,[],CHEMBL1679731,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 16 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70196,,,5211248,[],CHEMBL1679733,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 17 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70197,,,5211249,[],CHEMBL1679865,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 19 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
70198,,,5211250,[],CHEMBL1679867,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 20 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
70199,,,5211251,[],CHEMBL1679875,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 24 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70200,,,5211252,[],CHEMBL1679877,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 25 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70201,,,5211253,[],CHEMBL1679879,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 26 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70202,,,5211256,[],CHEMBL1678986,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 2 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70203,,,5211257,[],CHEMBL1678987,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 3 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70204,,,5211258,[],CHEMBL1678988,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 4 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70205,,,5211259,[],CHEMBL1678989,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 5 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70206,,,5211885,[],CHEMBL1675541,"Antimicrobial activity against Escherichia coli isolate 157 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 3 isolated from urine of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
70207,,,5211886,[],CHEMBL1675542,Antimicrobial activity against Escherichia coli isolate 157T expressing beta-lactamase KPC2 and PFGE cluster 3 isolated from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70208,,,5211887,[],CHEMBL1675543,"Antimicrobial activity against Escherichia coli isolate 329 expressing beta-lactamase KPC2, CTX-M-2, TEM and PFGE cluster 2 isolated from blood of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70209,,,5211888,[],CHEMBL1675544,Antimicrobial activity against Escherichia coli isolate 329T expressing beta-lactamase KPC2 and PFGE cluster 2 isolated from blood of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70210,,,5211889,[],CHEMBL1675545,"Antimicrobial activity against Escherichia coli isolate 339 expressing beta-lactamase KPC2, TEM and PFGE cluster 5 isolated from peritoneal fluid of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70211,,,5211890,[],CHEMBL1675546,Antimicrobial activity against Escherichia coli isolate 339T expressing beta-lactamase KPC2 and PFGE cluster 5 isolated from peritoneal fluid of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70212,,,5211891,[],CHEMBL1675547,"Antimicrobial activity against Escherichia coli isolate 360 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from urine of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.75
70213,,,5211892,[],CHEMBL1675548,"Antimicrobial activity against Escherichia coli isolate 360T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from urine of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70214,,,5211893,[],CHEMBL1675549,"Antimicrobial activity against Escherichia coli isolate 386 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from wound of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.75
70215,,,5211894,[],CHEMBL1675550,"Antimicrobial activity against Escherichia coli isolate 386T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from wound of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70216,,,5211895,[],CHEMBL1675551,"Antimicrobial activity against Escherichia coli isolate 540 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from synovial fluid of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70217,,,5211896,[],CHEMBL1675552,"Antimicrobial activity against Escherichia coli isolate 543 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 4 isolated from synovial fluid of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
70218,,,5211897,[],CHEMBL1675553,Antimicrobial activity against Escherichia coli isolate 543T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from synovial fluid of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70219,,,5211898,[],CHEMBL1675554,"Antimicrobial activity against Escherichia coli isolate 544 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from abscess of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
70220,,,5211899,[],CHEMBL1675555,"Antimicrobial activity against Escherichia coli isolate 547 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from blood of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70221,,,5211900,[],CHEMBL1675556,Antimicrobial activity against Escherichia coli isolate 547T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from blood of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70222,,,5211901,[],CHEMBL1675557,"Antimicrobial activity against Escherichia coli isolate 1679 expressing beta-lactamase KPC2, SHV-12, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70223,,,5211902,[],CHEMBL1675558,"Antimicrobial activity against Escherichia coli isolate 1679T expressing beta-lactamase KPC2, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
70224,,,5211903,[],CHEMBL1675559,Antimicrobial activity against Escherichia coli DH10B by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332146,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70225,,,5215063,[],CHEMBL1676100,"Drug penetration in blister fluid of healthy human at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,0,=,,Drug uptake,%,,74.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,74.0
70226,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5215064,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1676006,"Cmax in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1332756,=,1,1,=,,Cmax,nM,,717.14,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,ug ml-1,UO_0000065,,0.42
70227,,,5215065,[],CHEMBL1676088,"Drug recovery in wound interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,0,=,,Activity,%,,57.03,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,57.03
70228,,,5215066,[],CHEMBL1676089,"Drug recovery in thigh interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,0,=,,Activity,%,,53.48,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,53.48
70229,,,5215067,[],CHEMBL1676092,"Plasma protein binding diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses measured after 12 hr by ultrafiltration",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,1,=,,PPB,%,,100.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,100.0
70230,,,5215068,[],CHEMBL1676091,"Plasma protein binding diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses measured after 6 hr by ultrafiltration",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,1,=,,PPB,%,,80.3,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,80.3
70231,,,5215069,[],CHEMBL1676090,"Plasma protein binding diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses measured after 1 hr by ultrafiltration",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,1,=,,PPB,%,,35.6,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,35.6
70232,,,5215070,[],CHEMBL1676012,"fCmax in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332756,=,1,0,=,,Cmax_unbound,ug ml-1,,0.16,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax_unbound,ug ml-1,UO_0000274,,0.16
70233,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5215071,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1676015,"Cmax in wound interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1332756,=,1,1,=,,Cmax,nM,,273.2,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,0.16
70234,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5215072,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1676019,"Cmax in thigh interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1332756,=,1,1,=,,Cmax,nM,,307.35,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,0.18
70235,,,5215073,[],CHEMBL1676007,"Tmax in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,Tmax,hr,,1.13,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Tmax,hr,UO_0000032,,1.13
70236,,,5215074,[],CHEMBL1676013,"fTmax in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,Tmax,hr,,1.13,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Tmax,hr,UO_0000032,,1.13
70237,,,5215075,[],CHEMBL1676016,"Tmax in wound interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,Tmax,hr,,4.38,CHEMBL612558,,ADMET,,,,Tmax,hr,UO_0000032,,4.38
70238,,,5215076,[],CHEMBL1676020,"Tmax in thigh interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,Tmax,hr,,3.38,CHEMBL612558,,ADMET,,,,Tmax,hr,UO_0000032,,3.38
70239,,,5215077,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1676008,"AUC (0 to 24 hrs) in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,1,=,,AUC,ng.hr.mL-1,,3990.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,AUC,microg.hr/mL,,,3.99
70240,,,5215078,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1676014,"fAUC (0 to 24 hrs) in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,1,=,,AUC,ng.hr.mL-1,,2650.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,AUC,microg.hr/mL,,,2.65
70241,,,5215079,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1676017,"AUC (0 to 24 hrs) in wound interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,1,=,,AUC,ng.hr.mL-1,,2600.0,CHEMBL612558,,ADMET,,,,AUC,microg.hr/mL,,,2.6
70242,,,5215080,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1676021,"AUC (0 to 24 hrs) in thigh interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,1,=,,AUC,ng.hr.mL-1,,2520.0,CHEMBL612558,,ADMET,,,,AUC,microg.hr/mL,,,2.52
70243,,,5215081,[],CHEMBL1676009,"Terminal half life in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,T1/2,hr,,9.73,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,t1/2,hr,UO_0000032,,9.73
70244,,,5215082,[],CHEMBL1676018,"Terminal half life in wound interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,T1/2,hr,,24.88,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,24.88
70245,,,5215083,[],CHEMBL1676022,"Terminal half life in thigh interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1332756,=,1,1,=,,T1/2,hr,,15.96,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,15.96
70246,,,5215084,[],CHEMBL1676010,"Clearance at steady state in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0002759,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,1,=,,CL,mL.min-1.kg-1,,4.667,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,CLss,L/hr/kg,,,0.28
70247,,,5215085,[],CHEMBL1676011,"Volume of distribution at steady state in plasma of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0003041,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,1,=,,Vdss,L.kg-1,,3.95,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Vdss,L/Kg,UO_0000197,,3.95
70248,,,5215086,[],CHEMBL1676023,"Drug penetration in wound interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,0,=,,Drug uptake,%,,100.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,100.0
70249,,,5215087,[],CHEMBL1676024,"Drug penetration in thigh interstitial fluid of diabetic patient with chronic wound infection at 100 mg/kg, iv loading dose followed by 50 mg/kg, iv BID for 2 to 3 doses by microdialysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1332756,=,1,0,=,,Drug uptake,%,,98.94,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,98.94
70250,,,5215088,[],CHEMBL1676093,fAUC (0 to 24 hrs) to MIC for Staphylococcus aureus infected in thigh of ICR mouse,F,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,0,=,,fAUC/MIC,,,5.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fAUC/MIC,,,,5.7
70251,,,5215089,[],CHEMBL1676094,Ratio of AUC (0 to 24 hrs) in patient with complicated skin and skin structure infections to MIC for Staphylococcus aureus,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,0,=,,RatioAUC/MIC,,,17.9,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,17.9
70252,,,5215090,[],CHEMBL1676095,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332756,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.12
70253,,,5215091,[],CHEMBL1676096,Ratio of AUC (0 to 24 hrs) in plasma diabetic patient with chronic wound infection to MIC for methicillin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,0,=,,RatioAUC/MIC,,,33.25,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,33.25
70254,,,5215092,[],CHEMBL1676097,Ratio of fAUC (0 to 24 hrs) in plasma of diabetic patient with chronic wound infection to MIC for methicillin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000366,cell-free format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,0,=,,RatioAUC/MIC,,,22.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,RatioAUC/MIC,,,,22.1
70255,,,5215093,[],CHEMBL1676098,Ratio of AUC (0 to 24 hrs) in wound interstitial fluid of diabetic patient with chronic wound infection to MIC for methicillin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,0,=,,RatioAUC/MIC,,,21.7,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,21.7
70256,,,5215094,[],CHEMBL1676099,Ratio of AUC (0 to 24 hrs) in thigh interstitial fluid of diabetic patient with chronic wound infection to MIC for methicillin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671769,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1332756,=,1,0,=,,RatioAUC/MIC,,,21.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,RatioAUC/MIC,,,,21.0
70257,,,5228509,[],CHEMBL1678018,Antimicrobial activity against Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
70258,,,5228510,[],CHEMBL1678019,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70259,,,5228511,[],CHEMBL1678020,Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.015
70260,,,5228512,[],CHEMBL1678021,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.25
70261,,,5228513,[],CHEMBL1678022,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.12
70262,,,5228514,[],CHEMBL1678023,Antimicrobial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.06
70263,,,5228515,[],CHEMBL1678024,Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
70264,,,5228516,[],CHEMBL1678025,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
70265,,,5228517,[],CHEMBL1678026,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,0.06
70266,,,5228535,[],CHEMBL1678018,Antimicrobial activity against Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,0.25
70267,,,5228536,[],CHEMBL1678019,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,8.0
70268,,,5228537,[],CHEMBL1678020,Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,2.0
70269,,,5228538,[],CHEMBL1678021,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,2.0
70270,,,5228539,[],CHEMBL1678022,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,32.0
70271,,,5228540,[],CHEMBL1678023,Antimicrobial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,8.0
70272,,,5228541,[],CHEMBL1678024,Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,2.0
70273,,,5228542,[],CHEMBL1678025,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
70274,,,5228543,[],CHEMBL1678026,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC90,ug ml-1,UO_0000274,,8.0
70275,,,5228561,[],CHEMBL1678018,Antimicrobial activity against Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.12
70276,,,5228562,[],CHEMBL1678019,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,1.0
70277,,,5228563,[],CHEMBL1678020,Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.03
70278,,,5228564,[],CHEMBL1678021,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70279,,,5228565,[],CHEMBL1678022,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70280,,,5228566,[],CHEMBL1678023,Antimicrobial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,0.25
70281,,,5228567,[],CHEMBL1678024,Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70282,,,5228568,[],CHEMBL1678025,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70283,,,5228569,[],CHEMBL1678026,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332497,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC50,ug ml-1,UO_0000274,,8.0
70284,,,5298642,[],CHEMBL1690575,Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,2.0
70285,,,5298643,[],CHEMBL1690576,Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,2.0
70286,,,5298644,[],CHEMBL1690577,Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,2.0
70287,,,5298645,[],CHEMBL1690578,Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,2.0
70288,,,5298646,[],CHEMBL1690579,Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,2.0
70289,,,5298647,[],CHEMBL1690580,Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,2.0
70290,,,5298648,[],CHEMBL1690581,Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70291,,,5298649,[],CHEMBL1690582,Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70292,,,5298650,[],CHEMBL1690583,Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70293,,,5298651,[],CHEMBL1690584,Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70294,,,5298652,[],CHEMBL1690585,Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70295,,,5298653,[],CHEMBL1690703,Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70296,,,5298654,[],CHEMBL1690704,Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,>=,1,1,>=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
70297,,,5298655,[],CHEMBL1690705,Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,4.0
70298,,,5298656,[],CHEMBL1690706,Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,4.0
70299,,,5298657,[],CHEMBL1690707,Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,4.0
70300,,,5298658,[],CHEMBL1690708,Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,4.0
70301,,,5298659,[],CHEMBL1690709,Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,4.0
70302,,,5298660,[],CHEMBL1690710,Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,4.0
70303,,,5298661,[],CHEMBL1690711,Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70304,,,5298662,[],CHEMBL1690712,Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70305,,,5298663,[],CHEMBL1690713,Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70306,,,5298664,[],CHEMBL1690714,Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70307,,,5298665,[],CHEMBL1690715,Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70308,,,5298666,[],CHEMBL1690716,Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70309,,,5298667,[],CHEMBL1690717,Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338298,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
70310,,,5298760,[],CHEMBL1691611,"Clearance in patient with community or hospital-acquired pneumonia at 100 mg/kg, iv loading dose followed by 50 mg/kg administered every 12 hrs",A,,,BAO_0002759,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687817,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1338420,=,1,0,=,,CL,L/hr,,19.2,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,L/hr,,,19.2
70311,,,5298761,[],CHEMBL1691614,"Volume of distribution in central compartment in patient with community or hospital-acquired pneumonia at 100 mg/kg, iv loading dose followed by 50 mg/kg administered every 12 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687817,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Liter,1338420,=,1,0,=,,Vc,l,,65.2,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vc,l,UO_0000099,,65.2
70312,,,5298762,[],CHEMBL1691612,"Distributional clearance in patient with community or hospital-acquired pneumonia at 100 mg/kg, iv loading dose followed by 50 mg/kg administered every 12 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687817,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1338420,=,1,0,=,,CLd,L/hr,,85.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CLd,L/hr,,,85.1
70313,,,5298763,[],CHEMBL1691613,"Volume of distribution at steady state in patient with community or hospital-acquired pneumonia at 100 mg/kg, iv loading dose followed by 50 mg/kg administered every 12 hrs",A,,,BAO_0003041,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687817,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Liter,1338420,=,1,0,=,,Vdss,l,,398.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,l,UO_0000099,,398.0
70314,,,5300234,[],CHEMBL1693831,Antibacterial activity against wild type Staphylococcus aureus Smith ATCC 13709 by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.063
70315,,,5300235,[],CHEMBL1693832,Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate 161 harboring tet(M) gene by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70316,,,5300236,[],CHEMBL1693833,Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate 158 harboring tet(K) gene by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.063
70317,,,5300237,[],CHEMBL1693834,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
70318,,,5300238,[],CHEMBL1693957,Antibacterial activity against tetracycline-resistant Streptococcus pneumoniae isolate 160 harboring tet(M) gene by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
70319,,,5300239,[],CHEMBL1693958,Antibacterial activity against Escherichia coli ATCC 25922 by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70320,,,5300240,[],CHEMBL1693959,Antibacterial activity against tetracycline-resistant Escherichia coli isolate 155 harboring tet(A) gene by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
70321,,,5300241,[],CHEMBL1693960,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
70322,,,5300287,[],CHEMBL1693961,Inhibition of protein synthesis in Escherichia coli S30 extract by coupled transcription/translation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,IC50,ug.mL-1,,0.47,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,0.47
70323,,,5301251,[],CHEMBL1693962,Antibacterial activity against Staphylococcus aureus by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,<=,1,1,<=,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
70324,,,5301252,[],CHEMBL1693963,Antibacterial activity against Streptococcus pneumoniae by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,<=,1,1,<=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
70325,,,5301253,[],CHEMBL1693964,Antibacterial activity against Haemophilus influenzae by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
70326,,,5301254,[],CHEMBL1693965,Antibacterial activity against Escherichia coli by CLSI M07-A8 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70327,,,5301267,[],CHEMBL1693962,Antibacterial activity against Staphylococcus aureus by CLSI M07-A8 method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC50,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.063
70328,,,5301268,[],CHEMBL1693963,Antibacterial activity against Streptococcus pneumoniae by CLSI M07-A8 method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,<=,1,1,<=,,MIC50,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.016
70329,,,5301269,[],CHEMBL1693964,Antibacterial activity against Haemophilus influenzae by CLSI M07-A8 method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70330,,,5301270,[],CHEMBL1693965,Antibacterial activity against Escherichia coli by CLSI M07-A8 method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.25
70331,,,5301283,[],CHEMBL1693962,Antibacterial activity against Staphylococcus aureus by CLSI M07-A8 method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
70332,,,5301284,[],CHEMBL1693963,Antibacterial activity against Streptococcus pneumoniae by CLSI M07-A8 method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,<=,1,1,<=,,MIC90,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.016
70333,,,5301285,[],CHEMBL1693964,Antibacterial activity against Haemophilus influenzae by CLSI M07-A8 method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70334,,,5301286,[],CHEMBL1693965,Antibacterial activity against Escherichia coli by CLSI M07-A8 method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1339489,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70335,,,5301290,[],CHEMBL1693966,"AUC in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1339489,=,1,1,=,,AUC,ng.hr.mL-1,,1052.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,hr.ng/ml,,,1052.0
70336,,,5301294,[],CHEMBL1693967,"Clearance in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po",A,,,BAO_0002759,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1339489,=,1,1,=,,CL,mL.min-1.kg-1,,15.48,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,ml/hr.kg,,,929.0
70337,,,5301298,[],CHEMBL1693968,"Volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1339489,=,1,1,=,,Vd,L.kg-1,,6.119,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Vd,ml/kg,UO_0000197,,6119.0
70338,,,5301302,[],CHEMBL1693969,"Half life in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1339489,=,1,1,=,,T1/2,hr,,4.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,t1/2,hr,UO_0000032,,4.6
70339,,,5301306,[],CHEMBL1693970,"Oral bioavailability in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po",A,,,BAO_0003042,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1339489,=,1,1,=,,F,%,,1.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,1.1
70340,,,5301313,[],CHEMBL1693971,Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in iv dosed mouse septicemia model assessed as mouse protection after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1339489,=,1,0,=,,PD50,mg kg-1,,0.35,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,0.35
70341,,,5301314,[],CHEMBL1693972,Antibacterial activity against Escherichia coli ATCC 25922 infected in iv dosed mouse septicemia model assessed as mouse protection after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687901,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1339489,=,1,0,=,,PD50,mg kg-1,,2.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,2.1
70342,,,5304654,[],CHEMBL1695044,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 1 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70343,,,5304660,[],CHEMBL1695045,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 2 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70344,,,5304666,[],CHEMBL1695046,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 3 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70345,,,5304672,[],CHEMBL1695047,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 4 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70346,,,5304678,[],CHEMBL1695048,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 5 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70347,,,5304684,[],CHEMBL1695049,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 6 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70348,,,5304690,[],CHEMBL1695050,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae isolate 7 expressing beta-lactamase NDM-1 obtained from urine of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687843,Antimicrob Agents Chemother,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338531,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70349,,,5305433,[],CHEMBL1696168,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in absence of thymidine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337312,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70350,,,5305445,[],CHEMBL1696169,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in presence of thymidine,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337312,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70351,,,5306485,[],CHEMBL1696170,Antibacterial activity against revertant Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337312,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70352,,,5306497,[],CHEMBL1696171,Antibacterial activity against normal phenotype Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337312,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70353,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5306509,[],CHEMBL1696172,Cmax in human plasma,A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1337312,=,1,1,=,,Cmax,nM,,1707.48,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,ug ml-1,UO_0000065,,1.0
70354,,,5306521,[],CHEMBL1696173,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,=,1,1,=,,Fu,,,0.2,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,%,,,20.0
70355,,,5306541,[],CHEMBL1696167,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU after 5 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,=,1,0,=,,log10cfu,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,1.0
70356,,Active,5306551,[],CHEMBL1696181,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level after 24 hrs in presence of thymidine,F,,,BAO_0000375,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
70357,,,5306569,[],CHEMBL1696177,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein at up to 10'5 times MIC after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,=,1,0,=,,log10cfu,,,-1.11,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,-1.11
70358,,,5306581,[],CHEMBL1696178,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,=,1,0,=,,log10cfu,,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,0.8
70359,,,5306593,[],CHEMBL1696179,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level at up to 10'5 times MIC after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,=,1,0,=,,log10CFU/ml,,,-1.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,-1.75
70360,,,5306605,[],CHEMBL1696180,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1337312,=,1,0,=,,log10CFU/ml,,,1.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.31
70361,,,5306617,[],CHEMBL1696305,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth at pH 5.5 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337312,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70362,,,5306629,[],CHEMBL1696306,Antibacterial activity against normal phenotype Staphylococcus aureus in cation-adjusted MH 2 broth at pH 5.5 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337312,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70363,,,5313917,[],CHEMBL1690025,Antibacterial activity against Citrobacter spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614437,Citrobacter,Citrobacter,544.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70364,,,5313930,[],CHEMBL1690026,Antibacterial activity against Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.25
70365,,,5313931,[],CHEMBL1690026,Antibacterial activity against Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70366,,,5313944,[],CHEMBL1690027,Antibacterial activity against Enterobacter spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC50,ug ml-1,UO_0000274,,0.5
70367,,,5313945,[],CHEMBL1690027,Antibacterial activity against Enterobacter spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC90,ug ml-1,UO_0000274,,4.0
70368,,,5313958,[],CHEMBL1690028,Antibacterial activity against Klebsiella spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC50,ug ml-1,UO_0000274,,1.0
70369,,,5313959,[],CHEMBL1690028,Antibacterial activity against Klebsiella spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC90,ug ml-1,UO_0000274,,2.0
70370,,,5313972,[],CHEMBL1690029,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,4.0
70371,,,5313973,[],CHEMBL1690029,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,8.0
70372,,,5313980,[],CHEMBL1690030,Antibacterial activity against indole positive Proteae by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,2.0
70373,,,5313987,[],CHEMBL1690031,Antibacterial activity against Serratia spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL613282,Serratia sp.,Serratia sp.,616.0,,,MIC50,ug ml-1,UO_0000274,,2.0
70374,,,5314000,[],CHEMBL1690032,Antibacterial activity against Staphylococcus spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,0.25
70375,,,5314001,[],CHEMBL1690032,Antibacterial activity against Staphylococcus spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70376,,,5314014,[],CHEMBL1690033,Antibacterial activity against Acinetobacter spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC50,ug ml-1,UO_0000274,,2.0
70377,,,5314015,[],CHEMBL1690033,Antibacterial activity against Acinetobacter spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC90,ug ml-1,UO_0000274,,16.0
70378,,,5314028,[],CHEMBL1690034,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,16.0
70379,,,5314029,[],CHEMBL1690034,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338132,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,16.0
70380,,,5315533,[],CHEMBL1690240,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 56 (494) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
70381,,,5315534,[],CHEMBL1690239,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 152 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70382,,,5315535,[],CHEMBL1690241,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 156 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70383,,,5315536,[],CHEMBL1690242,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 145 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70384,,,5315537,[],CHEMBL1690243,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 336 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
70385,,,5315538,[],CHEMBL1690244,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 360 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70386,,,5315539,[],CHEMBL1690245,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 412 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70387,,,5315540,[],CHEMBL1690246,Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 38 (Mu3) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
70388,,,5315541,[],CHEMBL1690247,Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 443 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70389,,,5315542,[],CHEMBL1690248,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 435 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70390,,,5315543,[],CHEMBL1690249,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 440 (A6298) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70391,,,5315544,[],CHEMBL1690250,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 453 (NRS23) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70392,,,5315545,[],CHEMBL1690251,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 454 (NRS404) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338173,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70393,,,6220984,[],CHEMBL1788010,Antimicrobial activity against tetracycline-susceptible Streptococcus pneumoniae isolate 106 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.0156
70394,,,6220985,[],CHEMBL1788011,Antimicrobial activity against tetracycline-resistant Streptococcus pneumoniae isolate 160 harboring tetM gene by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.0156
70395,,,6220990,[],CHEMBL1788008,Antimicrobial activity against tetracycline-susceptible Enterococcus faecalis isolate 103 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0313,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.0313
70396,,,6220999,[],CHEMBL1788012,Antimicrobial activity against tetracycline-susceptible Escherichia coli isolate 107 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0313,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0313
70397,,,6221003,[],CHEMBL1787781,Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus isolate 101 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70398,,,6221007,[],CHEMBL1788007,Antimicrobial activity against tetracycline-resistant Staphylococcus aureus isolate 158 harboring tetK gene by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70399,,,6221011,[],CHEMBL1788009,Antimicrobial activity against tetracycline-resistant Enterococcus faecalis isolate 159 harboring teM gene by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70400,,,6221025,[],CHEMBL1788019,Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus Smith isolate 100 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70401,,,6221029,[],CHEMBL1788006,"Antimicrobial activity against methicillin-, tetracycline-resistant Staphylococcus aureus isolate 161 harboring tetM gene by CLSI dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70402,,,6221052,[],CHEMBL1788017,Antimicrobial activity against tetracycline-susceptible Klebsiella pneumoniae isolate 109 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
70403,,,6221127,[],CHEMBL1788014,Antimicrobial activity against tetracycline-susceptible Acinetobacter baumannii isolate 110 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
70404,,,6221129,[],CHEMBL1788016,Antimicrobial activity against tetracycline-susceptible Enterobacter cloacae isolate 108 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.25
70405,,,6221136,[],CHEMBL1786892,Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus Smith isolate 100 infected in iv dosed mouse systemic infection model assessed as survival of mouse administered 60 mins post infection measured up to 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1428432,=,1,0,=,,PD50,mg kg-1,,0.35,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,0.35
70406,,,6222477,[],CHEMBL1788013,Antimicrobial activity against tetracycline-resistant Escherichia coli isolate 155 harboring tetA gene by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
70407,,,6222581,[],CHEMBL1788018,Antimicrobial activity against tetracycline-resistant Klebsiella pneumoniae isolate 153 harboring tetA gene by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70408,,,6222587,[],CHEMBL1786890,Oral bioavailability in Sprague-Dawley rat at 10 mg/kg administered as single dose,A,,,BAO_0003042,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1428432,=,1,1,=,,F,%,,1.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,1.1
70409,,,6223933,[],CHEMBL1785307,"Elimination half life in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1428432,=,1,1,=,,T1/2,hr,,4.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,beta t1/2,hr,UO_0000032,,4.6
70410,,,6223941,[],CHEMBL1785306,"Apparent volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1428432,=,1,1,=,,Vd,L.kg-1,,6.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Vz,L/Kg,UO_0000197,,6.12
70411,,,6223995,[],CHEMBL1788015,Antimicrobial activity against tetracycline-susceptible Pseudomonas aeruginosa isolate 111 by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428432,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
70412,,,6224045,[],CHEMBL1785305,"Clearance in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs",A,,,BAO_0002759,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1428432,=,1,1,=,,CL,mL.min-1.kg-1,,15.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,ml/min.kg,,,15.5
70413,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,6225121,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1788020,"Cmax in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,1428432,=,1,1,=,,Cmax,nM,,730.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ng/ml,UO_0000065,,428.0
70414,,,6225132,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1785304,"AUC (0 to infinity) in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1428432,=,1,1,=,,AUC,ng.hr.mL-1,,1052.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ng.hr/ml,,,1052.0
70415,,Not Determined,6225326,[],CHEMBL1786891,Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus Smith isolate 100 infected in po dosed mouse systemic infection model assessed as survival of mouse administered 60 mins post infection measured after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1781932,J Med Chem,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1428432,,1,0,,,PD50,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,,,,
70416,,,7834697,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_bilirubinemia,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,1.0
70417,,,7834698,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
70418,,,7834699,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
70419,,,7834700,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
70420,,,7834701,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
70421,,,7834702,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_hepatic failure,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,1.0
70422,,,7834703,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
70423,,,7834704,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_hepatitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,0.0
70424,,,7834705,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
70425,,,7834706,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
70426,,,7834707,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
70427,,,7834708,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
70428,,,7834709,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_liver function tests abnormal,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,1.0
70429,,,7834710,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1541315,=,1,0,=,,HepSE_Combined Scores,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,4.0
70430,,,8035286,[],CHEMBL1953707,Antibacterial activity against tetracycline-resistant Klebsiella pneumoniae 153,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70431,,,8035307,[],CHEMBL1953706,Antibacterial activity against Klebsiella pneumoniae ATCC 109 13883,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
70432,,,8035328,[],CHEMBL1953705,Antibacterial activity against Enterobacter cloacae ATCC 108 13047,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.25
70433,,,8035349,[],CHEMBL1953704,Antibacterial activity against Pseudomonas aeruginosa ATCC 111 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
70434,,,8035370,[],CHEMBL1953703,Antibacterial activity against Acinetobacter baumannii ATCC 19606 110,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
70435,,,8035391,[],CHEMBL1953602,Antibacterial activity against tetracycline-resistant Escherichia coli 155,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
70436,,,8035412,[],CHEMBL1953601,Antibacterial activity against Escherichia coli ATCC 107 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70437,,,8035433,[],CHEMBL1953600,Antibacterial activity against tetracycline-resistant Streptococcus pneumoniae 160,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.0156
70438,,,8035454,[],CHEMBL1953599,Antibacterial activity against Streptococcus pneumoniae ATCC 106 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.0156
70439,,,8035475,[],CHEMBL1953598,Antibacterial activity against tetracycline-resistant Enterococcus faecalis 159,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70440,,,8036270,[],CHEMBL1953597,Antibacterial activity against Enterococcus faecalis ATCC 103 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70441,,,8036291,[],CHEMBL1953596,Antibacterial activity against tetracycline-resistant Staphylococcus aureus 158,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70442,,,8036312,[],CHEMBL1953595,Antibacterial activity against tetracycline- and methicillin-resistant Staphylococcus aureus 161,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70443,,,8036333,[],CHEMBL1953594,Antibacterial activity against Staphylococcus aureus ATCC 101 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70444,,,8036363,[],CHEMBL1953715,Antibacterial activity against tetracycline-resistant Escherichia coli 133 infected in iv dosed CD-1 mouse assessed as protection from infection administered 1 hr post infection measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,0,=,,PD50,mg kg-1,,3.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,3.5
70445,,,8036366,[],CHEMBL1953716,Antibacterial activity against tetracycline-resistant Escherichia coli 133 infected in iv dosed CD-1 mouse assessed as reduction in bacterial burden administered 1 hr post infection measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70446,,,8036369,[],CHEMBL1953717,Antibacterial activity against tetracycline-resistant Staphylococcus aureus 191 infected in iv dosed CD-1 mouse assessed as dose required for 1 log bacterial burden reduction administered 1.5 hr post infection measured after 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,0,=,,Activity,mg kg-1,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mg kg-1,UO_0000308,,3.0
70447,,,8036372,[],CHEMBL1953718,Antibacterial activity against tetracycline-resistant Staphylococcus aureus 191 infected in iv dosed CD-1 mouse assessed as dose required for 3 log bacterial burden reduction administered 1.5 hr post infection measured after 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,0,=,,Activity,mg kg-1,,17.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mg kg-1,UO_0000308,,17.3
70448,,,8036375,[],CHEMBL1953719,Antibacterial activity against tetracycline-resistant Staphylococcus aureus 191 infected in iv dosed CD-1 mouse assessed as reduction in bacterial burden administered 1.5 hr post infection measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1578561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70449,,,8036378,[],CHEMBL1953720,"Clearance in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,1,=,,CL,mL.min-1.kg-1,,15.48,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,L/hr/kg,,,0.929
70450,,,8036381,[],CHEMBL1953721,"Apparent volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis",A,,,BAO_0003040,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,1,=,,Vd,L.kg-1,,6.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Vz,L/Kg,UO_0000197,,6.12
70451,,,8036384,[],CHEMBL1953722,"Elimination half life in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1578561,=,1,1,=,,T1/2,hr,,4.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,beta t1/2,hr,UO_0000032,,4.6
70452,,,8036387,[],CHEMBL1953723,"Elimination half life in Sprague-Dawley rat at 10 mg/kg, po by LC/MS-MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,1578561,=,1,1,=,,T1/2,hr,,3.98,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,beta t1/2,hr,UO_0000032,,3.98
70453,,,8036390,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '0 - last', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': '0 - last', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1953724,"AUClast in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,1,=,,AUC,ng.hr.mL-1,,1052.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUClast,microg.hr/mL,,,1.052
70454,,,8036393,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '0 - last', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': '0 - last', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1954197,"AUClast in Sprague-Dawley rat at 10 mg/kg, po by LC/MS-MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,1578561,=,1,1,=,,AUC,ng.hr.mL-1,,107.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUClast,microg.hr/mL,,,0.107
70455,,,8036396,[],CHEMBL1954198,Oral bioavailability in Sprague-Dawley rat at 10 mg/kg by LC/MS-MS analysis,A,,,BAO_0003042,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL1949621,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1578561,=,1,1,=,,F,%,,1.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,1.0
70456,,,10950956,[],CHEMBL2060272,Antibacterial activity against Klebsiella pneumoniae ATCC 13883,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
70457,,,10951001,[],CHEMBL2060271,Antibacterial activity against Escherichia coli isolate EC155 expressing tetA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
70458,,,10951046,[],CHEMBL2060270,Antibacterial activity against Escherichia coli ATCC 25922 isolate 107,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70459,,,10951090,[],CHEMBL2060269,Antibacterial activity against tetracycline-resistant Streptococcus pneumoniae isolate 160 expressing tetM gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
70460,,,10951137,[],CHEMBL2060268,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolate 106,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
70461,,,10951181,[],CHEMBL2060267,Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate SA158 expressing TetK gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.063
70462,,,10951813,[],CHEMBL2060266,Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate SA161 expressing TetM gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
70463,,,10951858,[],CHEMBL2060265,Antibacterial activity against tetracycline-susceptible Staphylococcus aureus ATCC 13709 Smith isolate SA100,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655651,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.063
70464,,,10963469,[],CHEMBL2060277,Oral bioavailability in rat,A,,,BAO_0003042,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1655651,=,1,1,=,,F,%,,1.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,1.1
70465,,BLD,10963472,[],CHEMBL2060276,Oral bioavailability in CD1 mouse at 30 mg/kg,A,,,BAO_0003042,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1655651,,1,0,,,F,%,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,,UO_0000187,,
70466,,,10963492,[],CHEMBL2060274,"Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in CD-1 mouse assessed as increase in survival at 30 mg/kg, po administered as single dose 1 hr post infection measured after 48 hrs post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1655651,=,1,0,=,,Survival,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Survival,%,UO_0000187,,0.0
70467,,,10963504,[],CHEMBL2060273,"Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in CD-1 mouse assessed as increase in survival at 3 mg/kg, iv administered as single dose 1 hr post infection measured after 48 hrs post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL2057101,J Med Chem,2012.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,1655651,=,1,0,=,,Survival,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Survival,%,UO_0000187,,100.0
70468,,,15620506,[],CHEMBL3583603,Antibacterial activity against Staphylococcus aureus 101 ATCC 29213 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70469,,,15620525,[],CHEMBL3583604,"Antibacterial activity against methicillin-resistant, tet(M) tetracycline-resistant Staphylococcus aureus 161 assessed as bacterial growth inhibition by susceptibility testing assay",F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70470,,,15620544,[],CHEMBL3583605,Antibacterial activity against tet(K) tetracycline-resistant Staphylococcus aureus 158 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70471,,,15620563,[],CHEMBL3583606,Antibacterial activity against tet(M) tetracycline-resistant Enterococcus faecalis 327 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.125
70472,,,15620582,[],CHEMBL3583607,Antibacterial activity against tet(M) tetracycline-resistant Enterococcus faecium 404 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.0312,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.0312
70473,,,15620601,[],CHEMBL3584148,Antibacterial activity against tet(M) tetracycline-resistant Streptococcus pneumoniae 160 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.0156
70474,,,15620620,[],CHEMBL3584149,Antibacterial activity against Escherichia coli 107 ATCC 25922 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70475,,,15620639,[],CHEMBL3584150,Antibacterial activity against tet(A) tetracycline-resistant Escherichia coli 155 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
70476,,,15620658,[],CHEMBL3584151,Antibacterial activity against Klebsiella pneumoniae 457 harboring CTX-M-15 gene assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70477,,,15620677,[],CHEMBL3584152,Antibacterial activity against Proteus mirabilis 385 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,4.0
70478,,,15620696,[],CHEMBL3584153,Antibacterial activity against Pseudomonas aeruginosa 555 BAA-47 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
70479,,,15620715,[],CHEMBL3584154,Antibacterial activity against tet(A) tetracycline-resistant Enterobacter cloacae 603 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,4.0
70480,,,15620734,[],CHEMBL3584155,Antibacterial activity against tet(B) tetracycline-resistant Acinetobacter baumannii 250 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
70481,,,15620753,[],CHEMBL3584156,Antibacterial activity against Stenotrophomonas maltophilia 256 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2.0
70482,,,15620772,[],CHEMBL3584157,Antibacterial activity against Burkholderia cenocepacia 240 assessed as bacterial growth inhibition by susceptibility testing assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3580574,J Med Chem,2015.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2482777,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301412,Burkholderia cenocepacia,Burkholderia cenocepacia,95486.0,,,MIC,ug ml-1,UO_0000274,,16.0
70483,,,16801122,[],CHEMBL3868706,Antibacterial activity against Staphylococcus aureus USA300,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2808885,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70484,,,16801123,[],CHEMBL3868707,Antibacterial activity against Staphylococcus aureus USA400,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2808885,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
70485,,,16801124,[],CHEMBL3868709,Antibacterial activity against Staphylococcus aureus USA300 in mouse thigh wound infection model assessed as reduction in bacterial load administered intravenously as single dose after 2 hrs of infection measured after 24 hrs post treatment,F,,,BAO_0003036,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2808885,=,1,1,=,,ED50,mg.kg-1,,0.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,0.45
70486,,,16801125,[],CHEMBL3868710,Antibacterial activity against Staphylococcus aureus USA400 in mouse thigh wound infection model assessed as reduction in bacterial load administered intravenously as single dose after 2 hrs of infection measured after 24 hrs post treatment,F,,,BAO_0003036,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2808885,=,1,1,=,,ED50,mg.kg-1,,0.46,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,0.46
70487,,,16801126,[],CHEMBL3868708,Antibacterial activity against Streptococcus pneumoniae PBS1399,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2808885,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
70488,,,16801127,[],CHEMBL3868711,Antibacterial activity against Streptococcus pneumoniae PBS1399 infected in mouse assessed as protection against bacterial infection by measuring mouse survival administered intravenously as single dose after 2 hrs of infection measured on day 7,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2808885,=,1,0,=,,PD50,mg kg-1,,0.91,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,0.91
70489,,,16801128,[],CHEMBL3868712,Antibacterial activity against Haemophilus influenzae PBS981,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2808885,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
70490,,,16801129,[],CHEMBL3868713,Antibacterial activity against Haemophilus influenzae PBS981 infected in CD-1 mouse assessed as reduction in bacterial load in lungs administered intravenously as single dose after 2 hrs of infection measured after 24 hrs post treatment,F,,,BAO_0003036,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2808885,=,1,1,=,,ED50,mg.kg-1,,2.31,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,ED50,mg kg-1,UO_0000308,,2.31
70491,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,16801130,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL3868729,"Cmax in human at 50 mg, iv q12h",A,,,BAO_0002119,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,2808885,=,1,1,=,,Cmax,nM,,1485.5,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,0.87
70492,,,16801131,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL3868730,"AUC(0 to 24 hrs) in human at 50 mg, iv q12h",A,,,BAO_0002120,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2808885,=,1,1,=,,AUC,ng.hr.mL-1,,4.7,CHEMBL612558,,ADMET,,,,AUC,ug.hr/L,,,4.7
70493,,,16801132,[],CHEMBL3868731,"Systemic clearance in human at 50 mg, iv q12h",A,,,BAO_0002759,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2808885,=,1,0,=,,CL,L/hr,,23.8,CHEMBL612558,,ADMET,,,,CL,L/hr,,,23.8
70494,,,16801133,[],CHEMBL3868732,"Terminal half life in human at 50 mg, iv q12h",A,,,BAO_0002115,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Hour,2808885,=,1,1,=,,T1/2,hr,,37.0,CHEMBL612558,,ADMET,,,,beta t1/2,hr,UO_0000032,66.0,37.0
70495,,,16801134,[],CHEMBL3868734,Protein binding in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL3868582,Bioorg Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,2808885,=,1,1,=,,PPB,%,,69.0,CHEMBL612546,,Molecular identity unknown,,,,PPB,%,UO_0000187,87.0,69.0
70496,,,18043527,[],CHEMBL4010212,"Antibacterial activity against Pseudomonas aeruginosa PA1145 in BALB/c mouse model of lung infection assessed as reduction in log10CFU per gram of lung at 40 mg/kg, iv bid administered 2 to 12 hrs of post-infection measured after 24 hrs relative to untreated control",F,,,BAO_0000181,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,2990078,=,1,0,=,,Activity,deltalog10CFU,,4.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,deltalog10CFU,,,4.2
70497,,,18043532,[],CHEMBL4010209,Antibacterial activity against Pseudomonas aeruginosa PA1145 in BALB/c mouse model of lung infection administered as iv bid for 2 to 12 hrs of post-infection measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
70498,,,18043624,[],CHEMBL4010236,Antibacterial activity against gram-positive Streptococcus pneumoniae SP160 harboring tet(M) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.0156
70499,,,18043631,[],CHEMBL4010227,Antibacterial activity against gram-positive Enterococcus faecium EFm404 harboring tet(M) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.0312,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.0312
70500,,,18043633,[],CHEMBL4010232,Antibacterial activity against gram-positive Staphylococcus aureus SA101 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
70501,,,18043642,[],CHEMBL4010233,Antibacterial activity against gram-positive Staphylococcus aureus SA161 harboring tet(M) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70502,,,18043647,[],CHEMBL4010234,Antibacterial activity against gram-positive Staphylococcus aureus SA158 harboring tet(K) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
70503,,,18043650,[],CHEMBL4010238,Antibacterial activity against gram-negative Escherichia coli EC107 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
70504,,,18043652,[],CHEMBL4010226,Antibacterial activity against gram-positive Enterococcus faecalis EFs327 harboring tet(M) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.125
70505,,,18043700,[],CHEMBL4010239,Antibacterial activity against gram-negative Escherichia coli EC155 harboring tet(A) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
70506,,,18043718,[],CHEMBL4010228,Antibacterial activity against gram-negative Klebsiella pneumoniae KP457 harboring blacTX-M-15 extended spectrum beta-lactamase gene by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70507,,,18043744,[],CHEMBL4010224,Antibacterial activity against gram-negative Stenotrophomonas maltophilia SM256 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2.0
70508,,,18043775,[],CHEMBL4010229,Antibacterial activity against gram-negative Proteus mirabilis PM385 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,4.0
70509,,,18043779,[],CHEMBL4010231,Antibacterial activity against gram-negative Enterobacter cloacae EC1603 harboring tet(A) by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,4.0
70510,,,18043785,[],CHEMBL4010223,Antibacterial activity against gram-negative Acinetobacter baumannii AB250 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
70511,,,18043813,[],CHEMBL4010225,Antibacterial activity against gram-negative Burkholderia cenocepacia BC240 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301412,Burkholderia cenocepacia,Burkholderia cenocepacia,95486.0,,,MIC,ug ml-1,UO_0000274,,16.0
70512,,,18043820,[],CHEMBL4010230,Antibacterial activity against gram-negative Pseudomonas aeruginosa PA555 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4007456,J Med Chem,2017.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990078,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
70513,,,18129532,[],CHEMBL4028921,Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3006870,>,1,1,>,,IC50,nM,,133000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,133.0
70514,,,18130105,[],CHEMBL4028922,Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3006870,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5748,Homo sapiens,Canalicular multispecific organic anion transporter 1,9606.0,,,IC50,uM,UO_0000065,,133.0
70515,,,18130702,[],CHEMBL4028923,Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3006870,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5918,Homo sapiens,Canalicular multispecific organic anion transporter 2,9606.0,,,IC50,uM,UO_0000065,,133.0
70516,,,18131302,[],CHEMBL4028924,Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3006870,>,1,1,>,,IC50,nM,,133000.0,CHEMBL1743128,Homo sapiens,Multidrug resistance-associated protein 4,9606.0,,,IC50,uM,UO_0000065,,133.0
70517,,,18133344,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3007742,=,1,0,=,,DILI_severity_class,,,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,8.0
70518,,Ambiguous-Dili-Concern,18133673,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3007742,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
70519,,,18659871,[],CHEMBL4231968,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Enterobacter cloacae 13-1 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
70520,,,18659872,[],CHEMBL4231967,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Enterobacter cloacae CDC1000654 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,8.0
70521,,,18659873,[],CHEMBL4231966,Antibacterial activity against carbapenem-resistant Enterobacter aerogenes 11-4 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,1.0
70522,,,18659874,[],CHEMBL4231965,Antibacterial activity against carbapenem-resistant Acinetobacter calcoaceticus 12-6 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,1.0
70523,,,18659875,[],CHEMBL4231964,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Acinetobacter calcoaceticus 13-1 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.5
70524,,,18659876,[],CHEMBL4231963,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae 12-12 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70525,,,18659877,[],CHEMBL4231962,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae 12-11 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70526,,,18659878,[],CHEMBL4231961,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Klebsiella pneumoniae 13-1 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70527,,,18659879,[],CHEMBL4231959,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli 13-1 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
70528,,,18659880,[],CHEMBL4231960,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli CDC1001728 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
70529,,,18659881,[],CHEMBL4231952,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Klebsiella pneumoniae ATCC BAA-2146 after 18 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4229379,Eur J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099161,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
70530,,,18828963,[],CHEMBL4303819,Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4303097,,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3135505,=,52,0,=,,Inhibition index,,,0.08555,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition index,,,,0.085553772
70531,,,18836021,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4303122,,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3142291,=,52,0,=,,Hit score,,,0.1712,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.171159453
70532,,,18849913,[],CHEMBL4305647,Antivirulence activity in Acinetobacter baumannii 4106 infected Galleria mellonella larvae model assessed as survival rate at 100 mg/kg measured at 24 hrs interval over 4 days,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4304756,ACS Med Chem Lett,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,3146048,=,1,0,=,,Activity,%,,20.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,20.0
70533,,,18927971,[],CHEMBL4325047,Antibacterial activity against Citrobacter freundii assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,1.0
70534,,,18927972,[],CHEMBL4325048,Antibacterial activity against Enterobacter aerogenes assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC90,ug ml-1,UO_0000274,,1.0
70535,,,18927973,[],CHEMBL4325049,Antibacterial activity against Enterobacter cloacae assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,4.0
70536,,,18927974,[],CHEMBL4325050,Antibacterial activity against Escherichia coli assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.0
70537,,,18927975,[],CHEMBL4325051,Antibacterial activity against Klebsiella oxytoca assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70538,,,18927976,[],CHEMBL4325052,Antibacterial activity against Klebsiella pneumoniae assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,4.0
70539,,,18927977,[],CHEMBL4325053,Antibacterial activity against Morganella morganii assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,8.0
70540,,,18927978,[],CHEMBL4325054,Antibacterial activity against Proteus mirabilis assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,4.0
70541,,,18927979,[],CHEMBL4325055,Antibacterial activity against Serratia marcescens assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,2.0
70542,,,18927980,[],CHEMBL4325056,Antibacterial activity against Acinetobacter baumannii assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,16.0
70543,,,18927981,[],CHEMBL4325057,Antibacterial activity against Burkholderia cepacia assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC90,ug ml-1,UO_0000274,,16.0
70544,,,18927982,[],CHEMBL4325058,Antibacterial activity against Haemophilus influenzae assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.25
70545,,,18927983,[],CHEMBL4325059,Antibacterial activity against Moraxella catarrhalis assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70546,,,18927984,[],CHEMBL4325060,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,16.0
70547,,,18927985,[],CHEMBL4325061,Antibacterial activity against Stenotrophomonas maltophilia assessed as reduction in bacterial growth by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4321867,J Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157651,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,4.0
70548,,,18970097,[],CHEMBL4336480,Antibacterial activity against carbapenem-resistant Escherichia coli BAA-2452 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4334464,J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164461,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
70549,,,18970111,[],CHEMBL4336481,Antibacterial activity against carbapenem-resistant Escherichia coli BAA-2469 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4334464,J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164461,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
70550,,,18970125,[],CHEMBL4336482,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae ATCC BAA-1705 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4334464,J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164461,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
70551,,,18970138,[],CHEMBL4336483,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae ATCC BAA-2146 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4334464,J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164461,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
70552,,,18970153,[],CHEMBL4336484,Antibacterial activity against carbapenem-resistant Acinetobacter baumannii ATCC BAA 1605 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4334464,J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164461,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
70553,,,18970167,[],CHEMBL4336485,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa ATCC 1744 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4334464,J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164461,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
70554,,,19084246,[],CHEMBL4364428,Inhibition of Dicer mediated biotinylated pre-miRNA-21 (unknown origin) maturation at 1 mM measured after 15 mins by cat-ELCCA relative to control,B,,,BAO_0000201,BAO_0000225,nucleic acid format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4364240,ACS Med Chem Lett,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,3183940,=,1,1,=,,Inhibition,%,,40.0,CHEMBL1615322,Homo sapiens,microRNA 21,9606.0,,,INH,%,UO_0000187,100.0,40.0
70555,,,19200867,[],CHEMBL4391674,Antibacterial activity against multi-drug resistant Escherichia coli NMI 3548/14 assessed as reduction in microbial growth incubated for 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4390654,Eur J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204804,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
70556,,,19200899,[],CHEMBL4391675,Antibacterial activity against multi-drug resistant Escherichia coli NMI 3898/15 assessed as reduction in microbial growth incubated for 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4390654,Eur J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204804,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
70557,,,19200931,[],CHEMBL4391676,Antibacterial activity against multi-drug resistant Klebsiella pneumoniae NMI 2697/14 assessed as reduction in microbial growth incubated for 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4390654,Eur J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204804,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
70558,,,19200963,[],CHEMBL4391677,Antibacterial activity against multi-drug resistant Klebsiella pneumoniae NMI 3081/09 assessed as reduction in microbial growth incubated for 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4390654,Eur J Med Chem,2019.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204804,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
70559,,No. Measurements = 1,22088936,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4651402,,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3494781,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
70560,,No. Measurements = 1,22088937,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4651402,,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3494781,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
70561,,,22767537,[],CHEMBL4703499,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70562,,,22767544,[],CHEMBL4703499,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
70563,,,22767551,[],CHEMBL4703499,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
70564,,,22767567,[],CHEMBL4703500,Antibacterial activity against hospital-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-811 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70565,,,22767579,[],CHEMBL4703501,Antibacterial activity against community-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-1556 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
70566,,,22767692,[],CHEMBL4703506,Antibacterial activity against Escherichia coli ATCC 25922 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
70567,,,22767765,[],CHEMBL4703508,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
70568,,,22767777,[],CHEMBL4703509,Antibacterial activity against Enterococcus faecium ATCC 35667 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.06
70569,,,22767789,[],CHEMBL4703510,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
70570,,,22767801,[],CHEMBL4703511,Antibacterial activity against Enterococcus faecalis ATCC 29212 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.12
70571,,,22767813,[],CHEMBL4703512,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
70572,,,22767825,[],CHEMBL4703513,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
70573,,,22767837,[],CHEMBL4703514,Antibacterial activity against Streptococcus anginosus ATCC 33397 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.06
70574,,Not Determined,22767849,[],CHEMBL4703515,Antibacterial activity against Haemophilus influenzae ATCC 43095 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3534536,,1,0,,,MIC,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,,,,
70575,,,22767914,[],CHEMBL4703526,Antibacterial activity against Vancomycin-resistant Enterococcus by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,0.06
70576,,,22767920,[],CHEMBL4703526,Antibacterial activity against Vancomycin-resistant Enterococcus by CLSI method,F,,,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC50,ug ml-1,UO_0000274,,0.25
70577,,,22767926,[],CHEMBL4703526,Antibacterial activity against Vancomycin-resistant Enterococcus by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4699558,Bioorg Med Chem,2020.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534536,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,0.5
70578,,,23260069,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832885,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-11 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.5
70579,,,23260100,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832886,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-12 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,1.0
70580,,,23260131,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832887,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-13 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,1.0
70581,,,23260162,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832888,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-14 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,1.0
70582,,,23260193,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832889,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-15 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.5
70583,,,23260224,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832890,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-16 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.25
70584,,,23260255,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832891,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-17 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.5
70585,,,23260286,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832892,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-18 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.25
70586,,,23260317,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832893,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-19 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.5
70587,,,23260348,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4832894,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-20 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL4831516,J Med Chem,2021.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618575,=,1,0,=,,MIC100,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC100,ug ml-1,UO_0000274,,0.5
70588,,,24844133,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IV', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IV', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '8.0'}]",CHEMBL5146154,"Invivo antibacterial activity against multidrug resistant Acinetobacter baumannii NCTC 13420 infected in mouse thigh infection model assessed in reduction in bacterial burden at 20 mg/kg, iv administered at 1 hr post infection and measured after 8 hrs (Rvb = 5.4 log10CFU/g)",F,,,BAO_0000181,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3880641,=,1,0,=,,Activity,log10CFU/g,,4.2,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,log10CFU/g,,,4.2
70589,,,24844138,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IV', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IV', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '8.0'}]",CHEMBL5146159,"Invivo antibacterial activity against multidrug resistant Acinetobacter baumannii NCTC 13420 infected in mouse thigh infection model assessed as log change in bacterial burden at 20 mg/kg, iv administered at 1 hr post infection and measured after 8 hrs relative to control",F,,,BAO_0000181,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3880641,=,1,0,=,,Activity,log10CFU/g,,-1.2,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,log10CFU/g,,,-1.2
70590,,,25052923,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '7.0'}]",CHEMBL5248003,Antibacterial activity against Acinetobacter baumannii NCTC 13301 producing OXA-23/51 infected in sc dosed Swiss albino mouse administered 1 hr post infection and measured upto 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247575,J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3926690,>,1,0,>,,PD50,mg kg-1,,6.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,PD50,mg kg-1,UO_0000308,,6.25
70591,,,25052924,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '7.0'}]",CHEMBL5248003,Antibacterial activity against Acinetobacter baumannii NCTC 13301 producing OXA-23/51 infected in sc dosed Swiss albino mouse administered 1 hr post infection and measured upto 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247575,J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3926690,>,1,0,>,,ED90,mg kg-1,,6.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,ED90,mg kg-1,UO_0000308,,6.25
70592,,,25052934,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '7.0'}]",CHEMBL5248005,Antibacterial activity against Acinetobacter baumannii NCTC 13303 producing OXA-26/51 infected in sc dosed Swiss albino mouse administered 2 hrs post infection and measured upto 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247575,J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3926690,>,1,0,>,,PD50,mg kg-1,,6.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,PD50,mg kg-1,UO_0000308,,6.25
70593,,,25052935,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '7.0'}]",CHEMBL5248005,Antibacterial activity against Acinetobacter baumannii NCTC 13303 producing OXA-26/51 infected in sc dosed Swiss albino mouse administered 2 hrs post infection and measured upto 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247575,J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,,3926690,>,1,0,>,,ED90,mg kg-1,,6.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,ED90,mg kg-1,UO_0000308,,6.25
70594,,,25052958,[],CHEMBL5248018,Antibacterial activity against Acinetobacter baumannii SL46 producing OXA-23/51 infected in Swiss mouse model of neutropenic lung infection,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247575,J Med Chem,2018.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3926690,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
70595,,,25065672,[],CHEMBL5251416,Antibacterial activity against multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928729,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
70596,,,25065684,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '8.0'}]",CHEMBL5251418,Antibacterial activity against multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition at 8 ug/ml by CLSI based broth microdilution method relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,3928729,=,1,0,=,,Activity,%,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,100.0
70597,,,25065686,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '8.0'}]",CHEMBL5251419,Antibacterial activity against non multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition at 8 ug/ml by CLSI based broth microdilution method relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://qudt.org/vocab/unit#Percent,3928729,=,1,0,=,,Activity,%,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,100.0
70598,,,25087155,[],CHEMBL5257271,Antimicrobial activity against Pseudomonas aeruginosa assessed as reduction in bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5257018,J Med Chem,2016.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3932817,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,16.0
70599,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117129,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
70600,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119215,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
70601,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120170,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,30.0
70602,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121301,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70603,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122498,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70604,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25123466,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
70605,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25125624,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,30.0
70606,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127620,[],CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
70607,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128989,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70608,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130118,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
70609,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131327,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70610,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25132534,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70611,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133725,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '7.80', 'le': '0.15', 'lle': '4.06', 'sei': '2.22'}",CHEMBL376140,TIGECYCLINE,CHEMBL376140,4.57,0,http://www.openphacts.org/units/Nanomolar,3941179,=,1,1,=,,AC50,nM,,26920.3,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,26.9203
70612,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134956,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,4.57,0,http://www.openphacts.org/units/Nanomolar,3941179,=,1,1,=,,AC50,nM,,26999.8,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,26.9998
70613,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25136221,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,30.0
70614,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137644,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70615,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25139842,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70616,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141085,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '7.52', 'le': '0.14', 'lle': '3.89', 'sei': '2.14'}",CHEMBL376140,TIGECYCLINE,CHEMBL376140,4.4,0,http://www.openphacts.org/units/Nanomolar,3941179,=,1,1,=,,AC50,nM,,39510.3,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,39.5103
70617,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25143219,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70618,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25144524,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
70619,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25146653,[],CHEMBL5291854,Agonist activity at human OPRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70620,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147382,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70621,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25148642,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70622,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149860,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
70623,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151998,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70624,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153588,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70625,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154805,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70626,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159194,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
70627,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25161647,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70628,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162834,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70629,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25165716,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,6.72,0,http://www.openphacts.org/units/Nanomolar,3941179,=,1,1,=,,AC50,nM,,189.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,0.189
70630,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166905,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
70631,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25168907,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70632,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170026,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70633,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171118,[],CHEMBL5291758,Binding affinity towards human CCKBR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL298,Homo sapiens,Cholecystokinin B receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70634,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25172282,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70635,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173914,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,6.8,0,http://www.openphacts.org/units/Nanomolar,3941179,=,1,1,=,,AC50,nM,,160.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,0.16
70636,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175417,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70637,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25176518,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70638,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177737,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70639,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25180044,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70640,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181341,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70641,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182913,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,30.0
70642,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184126,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,30.0
70643,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184831,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
70644,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186089,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,30.0
70645,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187175,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
70646,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187843,[],CHEMBL5291846,Binding affinity towards human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '9.60', 'le': '0.18', 'lle': '5.11', 'sei': '2.73'}",CHEMBL376140,TIGECYCLINE,CHEMBL376140,5.62,0,http://www.openphacts.org/units/Nanomolar,3941179,=,1,1,=,,AC50,nM,,2390.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,2.39
70647,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188715,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70648,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25190196,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
70649,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25193045,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70650,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25200195,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70651,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25212017,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70652,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213272,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
70653,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25214464,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
70654,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216552,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70655,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25219432,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70656,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25220613,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70657,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221802,[],CHEMBL5291861,Antagonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70658,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25222665,[],CHEMBL5291860,Agonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70659,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25224723,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70660,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225870,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70661,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227064,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70662,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228240,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL376140,TIGECYCLINE,CHEMBL376140,,0,http://www.openphacts.org/units/Nanomolar,3941179,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
70663,,,1265189,[],CHEMBL769868,Inhibitory activity against release of beta-hexosaminidase from RBL-2H3 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1136230,Bioorg Med Chem Lett,2003.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Nanomolar,204740,>,1,1,>,,IC50,nM,,100000.0,CHEMBL614632,Rattus norvegicus,RBL-2H3,10116.0,,,IC50,uM,UO_0000065,,100.0
70664,,,1265190,[],CHEMBL769880,Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control,F,,,BAO_0000201,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1136230,Bioorg Med Chem Lett,2003.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,204740,=,1,1,=,,Inhibition,%,,17.0,CHEMBL614632,Rattus norvegicus,RBL-2H3,10116.0,,,Inhibition,%,UO_0000187,,17.0
70665,,,1430368,[],CHEMBL876002,Inhibitory concentration of compound on nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages,F,,,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143515,Bioorg Med Chem Lett,2005.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,4.82,0,http://www.openphacts.org/units/Nanomolar,367914,=,1,1,=,,IC50,nM,,15000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,IC50,uM,UO_0000065,,15.0
70666,,,2140528,[],CHEMBL923180,Cytotoxicity against mouse L929 cells assessed as survival at 5 uM after 20 hrs by MTT method relative to control,A,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,96.2,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,96.2
70667,,,2140529,[],CHEMBL923181,Cytotoxicity against mouse L929 cells assessed as survival at 10 uM after 20 hrs by MTT method relative to control,A,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,96.5,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,96.5
70668,,,2140530,[],CHEMBL923182,Cytotoxicity against mouse L929 cells assessed as survival at 20 uM after 20 hrs by MTT method relative to control,A,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,75.7,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,75.7
70669,,,2140533,[],CHEMBL922072,Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 30 uM,F,,,BAO_0001103,BAO_0000252,mitochondrion format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Activity,%,,32.0,CHEMBL613642,Rattus norvegicus,Liver,10116.0,,,Activity,%,UO_0000187,,32.0
70670,,,2140534,[],CHEMBL923172,Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 60 uM,F,,,BAO_0001103,BAO_0000252,mitochondrion format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Activity,%,,48.0,CHEMBL613642,Rattus norvegicus,Liver,10116.0,,,Activity,%,UO_0000187,,48.0
70671,,,2140535,[],CHEMBL923173,Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 180 uM,F,,,BAO_0001103,BAO_0000252,mitochondrion format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Activity,%,,86.0,CHEMBL613642,Rattus norvegicus,Liver,10116.0,,,Activity,%,UO_0000187,,86.0
70672,,,2140541,[],CHEMBL923174,Protection against 30 mins photoirradiation-induced damage in rat liver mitochondria assessed as reduction of lipid hydroperoxide formation at 180 uM,F,,,BAO_0001103,BAO_0000252,mitochondrion format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Activity,%,,87.0,CHEMBL613642,Rattus norvegicus,Liver,10116.0,,,Activity,%,UO_0000187,,87.0
70673,,,2140548,[],CHEMBL922218,Prevention of 5 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 10 uM by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,94.2,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,94.2
70674,,,2140549,[],CHEMBL922219,Prevention of 10 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 10 uM by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,92.2,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,92.2
70675,,,2140550,[],CHEMBL922220,Prevention of 15 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 10 uM by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,82.9,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,82.9
70676,,,2140551,[],CHEMBL922221,Prevention of 5 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 5 uM by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,89.1,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,89.1
70677,,,2140552,[],CHEMBL922222,Prevention of 10 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 5 uM by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,88.3,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,88.3
70678,,,2140553,[],CHEMBL922223,Prevention of 15 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 5 uM by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Survival,%,,85.4,CHEMBL612267,Mus musculus,L929,10090.0,,,Survival,%,UO_0000187,,85.4
70679,,,2140554,[],CHEMBL922214,Prevention of 15 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 9 uM by MTT assay,F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1143957,Bioorg Med Chem,2008.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,703241,=,1,0,=,,Activity,%,,6.0,CHEMBL612267,Mus musculus,L929,10090.0,,,Activity,%,UO_0000187,,6.0
70680,,,2441377,[],CHEMBL961068,Cytotoxicity against human NUGC cells at 50 uM,F,,,BAO_0000201,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1158898,J Nat Prod,2003.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,714482,=,1,1,=,,Inhibition,%,,96.0,CHEMBL614207,Homo sapiens,NUGC,9606.0,,,INH,%,UO_0000187,,96.0
70681,,Not Active,3468542,[],CHEMBL1251361,Cytotoxicity against human MCF7 cells at 100 uM after 72 hrs by MTT assay,F,,,BAO_0000375,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1250531,Bioorg Med Chem,2010.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,955522,,1,0,,,Activity,,,,CHEMBL387,Homo sapiens,MCF7,9606.0,,,Activity,,,,
70682,,,5095563,[],CHEMBL1633666,Antimicrobial activity against Streptococcus mutans ATCC 25175 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,250.0
70683,,,5095564,[],CHEMBL1633667,Antimicrobial activity against Enterococcus faecium ATCC 8042 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,250.0
70684,,,5095565,[],CHEMBL1637147,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,250.0
70685,,,5095566,[],CHEMBL1637148,Antimicrobial activity against Streptococcus sanguis ATCC 10556 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,125.0
70686,,,5095567,[],CHEMBL1637149,Antimicrobial activity against Actinomyces viscosus ATCC 15987 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,MIC,ug ml-1,UO_0000274,,250.0
70687,,,5095568,[],CHEMBL1637150,Antimicrobial activity against Haemophilus actinomycetemcomitans ATCC 29522 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL614406,Aggregatibacter actinomycetemcomitans,Aggregatibacter actinomycetemcomitans,714.0,,,MIC,ug ml-1,UO_0000274,,250.0
70688,,,5095569,[],CHEMBL1637151,Antimicrobial activity against Prevotella intermedia ATCC 25611 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC,ug ml-1,UO_0000274,,125.0
70689,,,5095570,[],CHEMBL1637152,Antimicrobial activity against Fusobacterium nucleatum ATCC 10953 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,125.0
70690,,,5095571,[],CHEMBL1637153,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 by turbidimetric analysis,F,,,BAO_0002146,BAO_0000019,assay format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL614414,Porphyromonas gingivalis,Porphyromonas gingivalis,837.0,,,MIC,ug ml-1,UO_0000274,,62.5
70691,,,5095572,[],CHEMBL1637154,Bactericidal activity against Streptococcus mutans ATCC 25175 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,500.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MBC,ug ml-1,UO_0000274,,500.0
70692,,,5095573,[],CHEMBL1637155,Bactericidal activity against Enterococcus faecium ATCC 8042 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,500.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MBC,ug ml-1,UO_0000274,,500.0
70693,,,5095574,[],CHEMBL1637156,Bactericidal activity against Enterococcus faecalis ATCC 29212 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,250.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MBC,ug ml-1,UO_0000274,,250.0
70694,,,5095575,[],CHEMBL1637157,Bactericidal activity against Streptococcus sanguis ATCC 10556 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,125.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MBC,ug ml-1,UO_0000274,,125.0
70695,,,5095576,[],CHEMBL1637158,Bactericidal activity against Actinomyces viscosus ATCC 15987 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,500.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,MBC,ug ml-1,UO_0000274,,500.0
70696,,,5095577,[],CHEMBL1637159,Bactericidal activity against Haemophilus actinomycetemcomitans ATCC 29522 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,500.0,CHEMBL614406,Aggregatibacter actinomycetemcomitans,Aggregatibacter actinomycetemcomitans,714.0,,,MBC,ug ml-1,UO_0000274,,500.0
70697,,,5095578,[],CHEMBL1637160,Bactericidal activity against Prevotella intermedia ATCC 25611 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,125.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MBC,ug ml-1,UO_0000274,,125.0
70698,,,5095579,[],CHEMBL1637161,Bactericidal activity against Fusobacterium nucleatum ATCC 10953 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,125.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MBC,ug ml-1,UO_0000274,,125.0
70699,,,5095580,[],CHEMBL1637162,Bactericidal activity against Porphyromonas gingivalis ATCC 33277 after 24 hrs by turbidimetric analysis,F,,,BAO_0000179,BAO_0000019,assay format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,0,=,,MBC,ug ml-1,,62.5,CHEMBL614414,Porphyromonas gingivalis,Porphyromonas gingivalis,837.0,,,MBC,ug ml-1,UO_0000274,,62.5
70700,,,5095581,[],CHEMBL1637163,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as log reduction in bacterial growth at 250 ug/ml measured at 10 hrs by time kill analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,=,1,0,=,,logMIC,,,3.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,logMIC,,,,3.0
70701,,,5095582,[],CHEMBL1637164,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as reduction in bacterial growth at 2 times MIC measured at 8 hrs by time kill analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,>,1,0,>,,log10cfu,,,50.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,log10cfu,,,,50.0
70702,,,5095583,[],CHEMBL1637165,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as reduction in bacterial growth at 4 times MIC measured at 4 hrs by time kill analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,>,1,0,>,,log10cfu,,,50.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,log10cfu,,,,50.0
70703,,Dose-dependent effect,5095584,[],CHEMBL1637166,Antimicrobial activity against Streptococcus mutans ATCC 25175 after 12 hrs by time kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,Activity,,,,
70704,,tde,5095585,[],CHEMBL1637169,Antimicrobial activity against Streptococcus mutans ATCC 25175 at 125 to 500 ug/ml by time kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,Activity,,,,
70705,,Active,5095586,[],CHEMBL1637167,Antimicrobial activity against adherent cells of Streptococcus mutans ATCC 25175 at 1000 ug/ml,F,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,Activity,,,,
70706,,Active,5095587,[],CHEMBL1637168,Antimicrobial activity against adherent cells of Streptococcus mutans ATCC 25175 assessed as inhibition of water-insoluble glucan synthesis at 1000 ug/ml in presence of sucrose,F,,,BAO_0000201,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,1314739,,1,0,,,Inhibition,%,,,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,INH,,UO_0000187,,
70707,,,5095588,[],CHEMBL1637172,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as post antibiotic effect at 250 ug/ml,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Hour,1314739,=,1,0,=,,PAE,hr,,4.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,PAE,hr,UO_0000032,,4.0
70708,,,5095589,[],CHEMBL1637171,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as post antibiotic effect at 2 times MIC,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Hour,1314739,=,1,0,=,,PAE,hr,,6.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,PAE,hr,UO_0000032,,6.0
70709,,,5095590,[],CHEMBL1637173,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as post antibiotic effect at 2 times MIC,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Hour,1314739,=,1,0,=,,PAE,hr,,7.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,PAE,hr,UO_0000032,,7.0
70710,,,5095591,[],CHEMBL1637170,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as post antibiotic effect at 250 ug/ml,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Hour,1314739,=,1,0,=,,PAE,hr,,3.5,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,PAE,hr,UO_0000032,,3.5
70711,,,5095592,[],CHEMBL1637174,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation after 24 hrs by crystal violet staining,F,,,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,IC50,ug.mL-1,,500.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,IC50,ug ml-1,UO_0000274,,500.0
70712,,,5095593,[],CHEMBL1637175,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as inhibition of biofilm formation after 24 hrs by crystal violet staining,F,,,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,IC50,ug.mL-1,,500.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,IC50,ug ml-1,UO_0000274,,500.0
70713,,,5095594,[],CHEMBL1637176,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as eradication of preformed biofilm after 24 hrs by crystal violet staining,F,,,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,IC50,ug.mL-1,,500.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,IC50,ug ml-1,UO_0000274,,500.0
70714,,,5095595,[],CHEMBL1637177,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as eradication of preformed biofilm after 24 hrs by crystal violet staining,F,,,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314739,=,1,1,=,,IC50,ug.mL-1,,1000.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,IC50,ug ml-1,UO_0000274,,1000.0
70715,,Active,5095596,[],CHEMBL1637309,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as increase in membrane permeability at 1000 ug/ml after 30 mins by propidium iodide staining-based flow cytometry,F,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,Activity,,,,
70716,,Active,5095597,[],CHEMBL1637310,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as increase in membrane permeability at 1000 ug/ml after 30 mins by propidium iodide staining-based flow cytometry,F,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,,Activity,,,,
70717,,,5095598,[],CHEMBL1637311,Antioxidant activity in rat liver microsomes assessed as reduction in lipid peroxidation at 10 to 100 ug/ml by thiobarbituric acid assay,F,,,BAO_0000201,BAO_0000251,microsome format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,1314739,=,1,1,=,,Inhibition,%,,15.0,CHEMBL613694,Rattus norvegicus,Liver microsomes,10116.0,,,INH,%,UO_0000187,,15.0
70718,,Non-toxic,5095599,[],CHEMBL1637315,Cytotoxicity against human neutrophils at 2.5 to 10 ug/ml after 3 hrs by MTT assay,A,,,BAO_0000375,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
70719,,Active,5095600,[],CHEMBL1637312,Antiinflammatory activity against human neutrophils assessed as inhibition of LPS-stimulated TNFalpha production at 5 ug/ml after 3 hrs by FACS analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,1314739,,1,0,,,Inhibition,%,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,INH,,UO_0000187,,
70720,,Active,5095601,[],CHEMBL1637313,Antiinflammatory activity against human neutrophils assessed as inhibition of LPS-stimulated TNFalpha production at 2.5 ug/ml after 3 hrs by FACS analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,1314739,,1,0,,,Inhibition,%,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,INH,,UO_0000187,,
70721,,Active,5095602,[],CHEMBL1637314,Antiinflammatory activity against human neutrophils assessed as inhibition of LPS-stimulated TNFalpha production at 10 ug/ml after 3 hrs by FACS analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,1314739,,1,0,,,Inhibition,%,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,INH,,UO_0000187,,
70722,,Non-toxic,5095604,[],CHEMBL1637318,Toxicity in healthy human assessed as occurrence of tingling sensation,T,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
70723,,Non-toxic,5095605,[],CHEMBL1637317,Toxicity in healthy human assessed as occurrence of after taste,T,,,BAO_0000375,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL1629551,Antimicrob Agents Chemother,2009.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,1314739,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
70724,,,12565856,[],CHEMBL3069059,Nematocidal activity against Caenorhabditis elegans assessed as mortality,F,,,BAO_0000179,BAO_0000218,organism-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3046344,Annu Rev Phytopathol,2002.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1830773,=,1,0,=,,MEC,ug ml-1,,300.0,CHEMBL613135,Caenorhabditis elegans,Caenorhabditis elegans,6239.0,,,MEC,ug ml-1,UO_0000274,,300.0
70725,,,13950494,[],CHEMBL3131339,Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3124854,Eur J Med Chem,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,4.08,0,http://www.openphacts.org/units/Nanomolar,1973225,=,1,1,=,,IC50,nM,,83000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,uM,UO_0000065,,83.0
70726,,,13950503,[],CHEMBL3131340,Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3124854,Eur J Med Chem,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,4.26,0,http://www.openphacts.org/units/Nanomolar,1973225,=,1,1,=,,IC50,nM,,55000.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,IC50,uM,UO_0000065,,55.0
70727,,,15084464,[],CHEMBL3362060,Inhibition of alpha-glucosidase (unknown origin) using 3 mM p-NPG solution at 50 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3352738,Bioorg Med Chem Lett,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2270216,=,1,1,=,,Inhibition,%,,9.08,CHEMBL2608,Homo sapiens,Lysosomal alpha-glucosidase,9606.0,,,INH,%,UO_0000187,,9.08
70728,,,15084478,[],CHEMBL3362061,Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity at 1 uM after 2 mins by ORAC-RCoo assay,P,,,BAO_0000181,BAO_0000100,small-molecule physicochemical format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3352738,Bioorg Med Chem Lett,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Micromolar,2270216,=,1,0,=,,Activity,uM,,2.55,CHEMBL2362975,,No relevant target,,,,Activity,uM,UO_0000064,,2.55
70729,,,15084491,[],CHEMBL3362062,Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity at 10 uM after 2 mins by ORAC-RCoo assay,P,,,BAO_0000181,BAO_0000100,small-molecule physicochemical format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3352738,Bioorg Med Chem Lett,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Micromolar,2270216,=,1,0,=,,Activity,uM,,16.26,CHEMBL2362975,,No relevant target,,,,Activity,uM,UO_0000064,,16.26
70730,,,15084504,[],CHEMBL3362063,Antioxidant activity assessed as copper(I)ion reduction power at 1 uM after 1 hr by cupric ion reducing antioxidant capacity assay,P,,,BAO_0000181,BAO_0000100,small-molecule physicochemical format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3352738,Bioorg Med Chem Lett,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Micromolar,2270216,=,1,0,=,,Activity,uM,,1.55,CHEMBL2362975,,No relevant target,,,,Activity,uM,UO_0000064,,1.55
70731,,,15084517,[],CHEMBL3362064,Antioxidant activity assessed as copper(I)ion reduction power at 10 uM after 1 hr by cupric ion reducing antioxidant capacity assay,P,,,BAO_0000181,BAO_0000100,small-molecule physicochemical format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3352738,Bioorg Med Chem Lett,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Micromolar,2270216,=,1,0,=,,Activity,uM,,22.77,CHEMBL2362975,,No relevant target,,,,Activity,uM,UO_0000064,,22.77
70732,,,15084530,[],CHEMBL3362065,Metal chelating activity of the compound assessed as Cu2+ chelating activity at 10 uM by fluorescence assay relative to control,P,,,BAO_0001103,BAO_0000100,small-molecule physicochemical format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3352738,Bioorg Med Chem Lett,2014.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2270216,=,1,0,=,,Activity,%,,20.48,CHEMBL2362975,,No relevant target,,,,Activity,%,UO_0000187,,20.48
70733,,,15188147,[],CHEMBL3412440,Growth inhibition of human HepG2 cells at 50 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,29.3,CHEMBL395,Homo sapiens,HepG2,9606.0,,,GI,%,UO_0000187,,29.3
70734,,,15188148,[],CHEMBL3412439,Growth inhibition of human HepG2 cells at 30 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,27.2,CHEMBL395,Homo sapiens,HepG2,9606.0,,,GI,%,UO_0000187,,27.2
70735,,,15188149,[],CHEMBL3412438,Growth inhibition of human MCF7 cells at 50 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,44.1,CHEMBL387,Homo sapiens,MCF7,9606.0,,,GI,%,UO_0000187,,44.1
70736,,,15188150,[],CHEMBL3412437,Growth inhibition of human MCF7 cells at 30 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,36.9,CHEMBL387,Homo sapiens,MCF7,9606.0,,,GI,%,UO_0000187,,36.9
70737,,,15188151,[],CHEMBL3412436,Growth inhibition of human MIAPaCa2 cells at 50 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,42.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI,%,UO_0000187,,42.8
70738,,,15188152,[],CHEMBL3412435,Growth inhibition of human MIAPaCa2 cells at 30 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,41.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI,%,UO_0000187,,41.7
70739,,,15188153,[],CHEMBL3411828,Growth inhibition of human HL60 cells at 50 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,92.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI,%,UO_0000187,,92.4
70740,,,15188154,[],CHEMBL3411827,Growth inhibition of human HL60 cells at 30 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,88.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI,%,UO_0000187,,88.8
70741,,Active,15188170,[],CHEMBL3412612,Induction of apoptosis in human HL60 cells assessed as effect on morphology at 5 to 20 uM after 24 hrs by phase-contrast microscopy,F,,,BAO_0000375,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,2288140,,1,0,,,Activity,,,,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,,,,
70742,,Active,15188171,[],CHEMBL3412611,Induction of apoptosis in human HL60 cells assessed as apoptotic bodies formation at 5 to 20 uM after 24 hrs by Hoechst 33342-staining based fluorescence microscopy,F,,,BAO_0000375,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,2288140,,1,0,,,Activity,,,,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,,,,
70743,,,15188172,[],CHEMBL3412467,Reduction in mitochondrial membrane potential in human HL60 cells at 20 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,42.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,%,UO_0000187,,42.0
70744,,,15188173,[],CHEMBL3412466,Reduction in mitochondrial membrane potential in human HL60 cells at 15 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,26.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,%,UO_0000187,,26.0
70745,,,15189066,[],CHEMBL3412465,Reduction in mitochondrial membrane potential in human HL60 cells at 10 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,22.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,%,UO_0000187,,22.0
70746,,,15189067,[],CHEMBL3411825,Reduction in mitochondrial membrane potential in human HL60 cells at 5 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,17.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,%,UO_0000187,,17.0
70747,,,15189068,[],CHEMBL3412464,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,6.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,6.0
70748,,,15189069,[],CHEMBL3412463,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,67.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,67.0
70749,,,15189070,[],CHEMBL3412462,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,27.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,27.0
70750,,,15189071,[],CHEMBL3412461,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,10.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,10.0
70751,,,15189072,[],CHEMBL3412460,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,22.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,22.0
70752,,,15189073,[],CHEMBL3412459,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,61.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,61.0
70753,,,15189074,[],CHEMBL3412458,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,17.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,17.0
70754,,,15189075,[],CHEMBL3412457,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,10.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,10.0
70755,,,15189076,[],CHEMBL3412456,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 1%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,9.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,9.0
70756,,,15189077,[],CHEMBL3412455,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,54.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,54.0
70757,,,15189078,[],CHEMBL3412454,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,37.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,37.0
70758,,,15189079,[],CHEMBL3412453,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,9.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,9.0
70759,,,15189080,[],CHEMBL3412452,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 1%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,8.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,8.0
70760,,,15189081,[],CHEMBL3412451,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,57.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,57.0
70761,,,15189082,[],CHEMBL3412450,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,35.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,35.0
70762,,,15189083,[],CHEMBL3412449,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),F,,,BAO_0001103,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,Activity,%,,5.0,CHEMBL612546,,Molecular identity unknown,,,,Activity,%,UO_0000187,,5.0
70763,,,15189084,[],CHEMBL3412448,Growth inhibition of human HL60 cells after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,4.3,0,http://www.openphacts.org/units/Nanomolar,2288140,=,1,1,=,,IC50,nM,,50000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,50.0
70764,,,15189085,[],CHEMBL3412447,Growth inhibition of human SK-N-SH cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Nanomolar,2288140,>,1,1,>,,IC50,nM,,30000.0,CHEMBL614924,Homo sapiens,SK-N-SH,9606.0,,,IC50,uM,UO_0000065,,30.0
70765,,,15189086,[],CHEMBL3412446,Growth inhibition of human HepG2 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Nanomolar,2288140,>,1,1,>,,IC50,nM,,30000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,30.0
70766,,,15189087,[],CHEMBL3412445,Growth inhibition of human MCF7 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Nanomolar,2288140,>,1,1,>,,IC50,nM,,30000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,30.0
70767,,,15189088,[],CHEMBL3412444,Growth inhibition of human MIAPaCa2 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://www.openphacts.org/units/Nanomolar,2288140,>,1,1,>,,IC50,nM,,30000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,30.0
70768,,,15189089,[],CHEMBL3412443,Growth inhibition of human HL60 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,5.52,0,http://www.openphacts.org/units/Nanomolar,2288140,=,1,1,=,,IC50,nM,,3000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,3.0
70769,,,15189090,[],CHEMBL3412442,Growth inhibition of human SK-N-SH cells at 50 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,71.7,CHEMBL614924,Homo sapiens,SK-N-SH,9606.0,,,GI,%,UO_0000187,,71.7
70770,,,15189091,[],CHEMBL3412441,Growth inhibition of human SK-N-SH cells at 30 uM after 72 hrs by MTT assay,F,,,BAO_0000096,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL3407403,Eur J Med Chem,2015.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,http://qudt.org/vocab/unit#Percent,2288140,=,1,0,=,,GI,%,,34.2,CHEMBL614924,Homo sapiens,SK-N-SH,9606.0,,,GI,%,UO_0000187,,34.2
70771,,,18252094,[],CHEMBL4054650,"Potency index, ratio of allopurinol IC50 to compound IC50 for xanthine oxidase (unknown origin)",B,,,BAO_0000179,BAO_0000357,single protein format,C=CCc1ccc(O)c(O)c1,,,CHEMBL4052641,Eur J Med Chem,2017.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,,0,,3028836,=,1,0,=,,Ratio IC50,,,1.84,CHEMBL1929,Homo sapiens,Xanthine dehydrogenase,9606.0,,,Ratio IC50,,,,1.84
70772,,,18252095,[],CHEMBL4054649,Inhibition of xanthine oxidase (unknown origin) assessed as reduction in uric acid formation using xanthine as substrate after 4 mins by UV-Vis spectrophotometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,C=CCc1ccc(O)c(O)c1,,,CHEMBL4052641,Eur J Med Chem,2017.0,"{'bei': '31.81', 'le': '0.59', 'lle': '2.95', 'sei': '11.81'}",CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,4.78,0,http://www.openphacts.org/units/Nanomolar,3028836,=,1,1,=,,IC50,nM,,16700.0,CHEMBL1929,Homo sapiens,Xanthine dehydrogenase,9606.0,,,IC50,uM,UO_0000065,,16.7
70773,,,22436953,[],CHEMBL4677718,Anti-inflammatory activity in murine RAW264.7 cells assessed as inhibition of LPS-induced NO production,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCc1ccc(O)c(O)c1,,,CHEMBL4673299,Bioorg Med Chem Lett,2021.0,,CHEMBL111134,HYDROXYCHAVICOL,CHEMBL111134,5.32,0,http://www.openphacts.org/units/Nanomolar,3516109,=,1,1,=,,IC50,nM,,4800.0,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,IC50,uM,UO_0000065,,4.8
70774,,,83259,[],CHEMBL812362,Antibacterial activity against Streptococcus pyogenes 308A,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70775,,,83260,[],CHEMBL814112,Antibacterial activity against Staphylococcus aureus SG 511,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70776,,,83261,[],CHEMBL809480,Antibacterial activity against Staphylococcus aureus 285,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70777,,,83262,[],CHEMBL809481,Antibacterial activity against Staphylococcus aureus 503,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70778,,,83263,[],CHEMBL675498,Antibacterial activity against Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70779,,,83264,[],CHEMBL675499,Antibacterial activity against Escherichia coli 1507E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70780,,,83265,[],CHEMBL771681,Antibacterial activity against Pseudomonas aeruginosa 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70781,,,83266,[],CHEMBL771077,Antibacterial activity against Pseudomonas aeruginosa 1592E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70782,,,83267,[],CHEMBL771680,Antibacterial activity against Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70783,,,83268,[],CHEMBL803304,Antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70784,,,83269,[],CHEMBL703389,Antibacterial activity against Klebsiella aerogenes 1522E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70785,,,83270,[],CHEMBL679041,Antibacterial activity against Enterobacter cloacae 1321E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,275560,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70786,,,83271,[],CHEMBL625382,Stability to porcine renal DHP-I,A,,,BAO_0000179,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,0,=,,Relative t1/2,,,1.0,CHEMBL612558,,ADMET,,,,Relative t1/2,,,,1.0
70787,,,83272,[],CHEMBL621377,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,275560,=,1,1,=,,T1/2,hr,,0.0665,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,min,UO_0000032,,3.99
70788,,,83273,[],CHEMBL627918,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,1,=,,AUC,ng.hr.mL-1,,6383.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug min-1 ml-1,,,383.0
70789,,,83274,[],CHEMBL621802,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,A,,,BAO_0002759,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,1,=,,CL,mL.min-1.kg-1,,54.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cl,ml min-1 kg-1,,,54.2
70790,,,83275,[],CHEMBL719154,"In vivo therapeutic efficacy in systemic infections caused by Streptococcus pyogenes 77A in mice, at a single subcutaneous administration",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,0,=,,PD50,mg kg-1,,4.72,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,4.72
70791,,,83276,[],CHEMBL719155,"In vivo therapeutic efficacy in systemic infections caused by Staphylococcus aureus Y-80-1953 in mice, at a single subcutaneous administration",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,0,=,,PD50,mg kg-1,,4.49,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,4.49
70792,,,83277,[],CHEMBL719152,"In vivo therapeutic efficacy in systemic infections caused by Escherichia coli 078 in mice, at a single subcutaneous administration",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,0,=,,PD50,mg kg-1,,1.11,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.11
70793,,,83278,[],CHEMBL719153,"In vivo therapeutic efficacy in systemic infections caused by Pseudomonas aeruginosa 1771M in mice, at a single subcutaneous administration",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1136553,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,275560,=,1,0,=,,PD50,mg kg-1,,5.43,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,5.43
70794,,,126936,[],CHEMBL808753,In vitro minimum inhibitory concentration against Staphylococcus aureus CDC1.,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120738,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.19
70795,,,126937,[],CHEMBL808755,In vitro minimum inhibitory concentration against Staphylococcus aureus SN 7.,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120738,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
70796,,,126938,[],CHEMBL808754,In vitro minimum inhibitory concentration against Staphylococcus aureus SN 43.,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120738,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
70797,,,126939,[],CHEMBL858628,In vitro minimum inhibitory concentration against Staphylococcus aureus COL.,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120738,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
70798,,,147882,[],CHEMBL753148,In vitro antibacterial activity against SG 137 strain of Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg l-1,UO_0000274,,0.2
70799,,,147883,[],CHEMBL753147,In vitro antibacterial activity against ATCC 27853 strain of Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg l-1,UO_0000274,,0.4
70800,,,147884,[],CHEMBL674184,In vitro antibacterial activity against ATCC 25922 strain of Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg l-1,UO_0000274,,0.04
70801,,,147885,[],CHEMBL705180,In vitro antibacterial activity against ATCC 100331 strain of Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg l-1,UO_0000274,,0.04
70802,,,147886,[],CHEMBL807527,In vitro antibacterial activity against GN 12873 strain of Stenotrophomonas maltophilia,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg l-1,UO_0000274,,100.0
70803,,,147887,[],CHEMBL802009,In vitro antibacterial activity against SG 621 strain of Serratia marcescens,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,mg l-1,UO_0000274,,0.06
70804,,,147888,[],CHEMBL801143,In vitro antibacterial activity against SG 511 strain of Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1135500,J Med Chem,2002.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,192706,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg l-1,UO_0000274,,0.1
70805,,,700373,[],CHEMBL812024,In vitro antibacterial activity against Streptococcus pyogenes 308A,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70806,,,700374,[],CHEMBL810866,In vitro antibacterial activity against Staphylococcus aureus SG511,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70807,,,700375,[],CHEMBL810864,In vitro antibacterial activity against Staphylococcus aureus 285,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70808,,,700376,[],CHEMBL810865,In vitro antibacterial activity against Staphylococcus aureus 503,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70809,,,700377,[],CHEMBL680465,In vitro antibacterial activity against Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70810,,,700378,[],CHEMBL680467,In vitro antibacterial activity against Escherichia coli 1507E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70811,,,700379,[],CHEMBL772728,In vitro antibacterial activity against Pseudomonas aeruginosa 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70812,,,700380,[],CHEMBL772726,In vitro antibacterial activity against Pseudomonas aeruginosa 1592E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70813,,,700381,[],CHEMBL772727,In vitro antibacterial activity against Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70814,,,700382,[],CHEMBL801690,In vitro antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70815,,,700383,[],CHEMBL703213,In vitro antibacterial activity against Klebsiella aerogenes 1522E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70816,,,700384,[],CHEMBL673975,In vitro antibacterial activity against Enterobacter cloacae 1321E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348998,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70817,,,700385,[],CHEMBL662338,Relative t1/2 hydrolysis to meropenem by partially purified porcine renal DHP-1,F,,,BAO_0000179,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1132765,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,348998,=,1,0,=,,Relative t1/2,,,1.0,CHEMBL2626,Sus scrofa,Renal dipeptidase,9823.0,,,Relative t1/2,,,,1.0
70818,,,776777,[],CHEMBL810311,In vitro antibacterial activity of compound was measured on Staphylococcus aureus 209P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,47395,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
70819,,,776778,[],CHEMBL810313,In vitro antibacterial activity of compound was measured on Staphylococcus aureus 3004(MRSA),F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,47395,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
70820,,,776779,[],CHEMBL680456,In vitro antibacterial activity of compound was measured on Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,47395,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70821,,,776780,[],CHEMBL767773,In vitro antibacterial activity of compound was measured on Proteus vulgaris IAM 1025,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,47395,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.1
70822,,,776781,[],CHEMBL858597,In vitro antibacterial activity of compound was measured on Pseudomonas aeruginosa 26,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,47395,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
70823,,,776782,[],CHEMBL771575,In vitro antibacterial activity of compound was measured on Pseudomonas aeruginosa IAM 1095,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,47395,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
70824,,,776783,[],CHEMBL662334,In vitro rate of hydrolysis by human dehydropeptidase-1 compared to meropenem.,F,,,BAO_0000179,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,47395,=,1,0,=,,DHP-I stability,,,1.0,CHEMBL2626,Sus scrofa,Renal dipeptidase,9823.0,,,DHP-I stability,,,,1.0
70825,,,776784,[],CHEMBL722031,Protective activity of compound against lethal systemic infection by Staphylococcus aureus 8008 (MRSA) in ICR mice at 1 hr after sc administration,F,,,BAO_0003036,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130441,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,47395,=,1,1,=,,ED50,mg.kg-1,,7.88,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,7.88
70826,,,805760,[],CHEMBL811009,In vivo antibacterial activity against Streptococcus pyogenes 77A,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.002
70827,,,805761,[],CHEMBL811313,In vivo antibacterial activity against Streptococcus faecium MD 8b,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,12.5
70828,,,805762,[],CHEMBL808662,In vivo antibacterial activity against Staphylococcus aureus SG 511,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70829,,,805763,[],CHEMBL878410,In vivo antibacterial activity against Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.013
70830,,,805764,[],CHEMBL676368,In vivo antibacterial activity against Escherichia coli 1507E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70831,,,805765,[],CHEMBL766606,In vivo antibacterial activity against Pseudomonas aeruginosa 1592E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70832,,,805766,[],CHEMBL766607,In vivo antibacterial activity against Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70833,,,805767,[],CHEMBL798168,In vivo antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.025
70834,,,805768,[],CHEMBL703218,In vivo antibacterial activity against Klebsiella aerogenes 1522E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70835,,,805769,[],CHEMBL679453,In vivo antibacterial activity against Enterobacter cloacae 1321E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,140295,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70836,,,805770,[],CHEMBL660614,Relative hydrolysis to meropenem by partially purified porcine renal Dehydropeptidase-1 was reported.,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Percent,140295,=,1,1,=,,Stability,%,,100.0,CHEMBL2626,Sus scrofa,Renal dipeptidase,9823.0,,,Stability,,UO_0000187,,1.0
70837,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,805771,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL622750,Maximum plasma concentration was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/Nanomolar,140295,=,1,1,=,,Cmax,nM,,40602.92,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,15.57
70838,,,805772,[],CHEMBL876413,Maximum time was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,BAO_0003037,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,140295,=,1,1,=,,Tmax,hr,,0.17,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T max,hr,UO_0000032,,0.17
70839,,,805773,[],CHEMBL627091,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,140295,=,1,1,=,,T1/2,hr,,0.27,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,hr,UO_0000032,,0.27
70840,,,805774,[],CHEMBL622481,Area under curve (AUC) was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,140295,=,1,1,=,,AUC,ng.hr.mL-1,,6860.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug hr ml-1,,,6.86
70841,,,805775,[],CHEMBL622481,Area under curve (AUC) was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,140295,=,1,0,=,,AUC,hr,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,hr,UO_0000032,,0.0
70842,,,805776,[],CHEMBL821361,In vivo therapeutic efficacy was determined against Escherichia coli 078 by a single sc administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,140295,=,1,0,=,,PD50,mg kg-1,,0.65,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.65
70843,,,805777,[],CHEMBL821363,In vivo therapeutic efficacy was determined against Staphylococcus aureus Y-80-1953 by a single sc administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,140295,=,1,0,=,,PD50,mg kg-1,,11.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,11.1
70844,,,805778,[],CHEMBL821364,In vivo therapeutic efficacy was determined against Streptococcus pyogenes 77A by a single sc administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,140295,=,1,0,=,,PD50,mg kg-1,,4.55,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,4.55
70845,,,805779,[],CHEMBL821362,In vivo therapeutic efficacy was determined against Pseudomonas aeruginosa 1771M by a single sc administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1131843,Bioorg Med Chem Lett,1999.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,140295,=,1,0,=,,PD50,mg kg-1,,4.26,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,4.26
70846,,,812287,[],CHEMBL804481,Minimum inhibitory concentration required for antibacterial activity against Staphylococcus aureus 209P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,123627,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
70847,,,812288,[],CHEMBL805129,Minimum inhibitory concentration required for antibacterial activity against methicillin-resistant Staphylococcus aureus 3004,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,123627,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
70848,,,812289,[],CHEMBL678940,Minimum inhibitory concentration required for antibacterial activity against Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,123627,<,1,1,<,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70849,,,812290,[],CHEMBL772559,Minimum inhibitory concentration required for antibacterial activity against Proteus vulgaris IAM 1025,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,123627,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.1
70850,,,812291,[],CHEMBL762954,Minimum inhibitory concentration required for antibacterial activity against Pseudomonas aeruginosa 26,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,123627,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
70851,,,812292,[],CHEMBL664507,In vitro renal dehydropeptidase I (DHP-I) stability relative to meropenem,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Percent,123627,=,1,1,=,,Stability,%,,100.0,CHEMBL1989,Homo sapiens,Renal dipeptidase,9606.0,,,Stability,,UO_0000187,,1.0
70852,,,812293,[],CHEMBL722240,In vitro percent urinary recovery in mice after subcutaneous administration at a dose of 20 mg/Kg,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128830,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Percent,123627,=,1,0,=,,Recovery,%,,25.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Recovery,%,UO_0000187,,25.0
70853,,,883883,[],CHEMBL808957,Antibacterial activity against Streptococcus pyogenes 77A,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.002
70854,,,883884,[],CHEMBL812909,Antibacterial activity against Streptococcus faecium MD 8b,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,12.5
70855,,,883885,[],CHEMBL807856,Antibacterial activity against Staphylococcus aureus SG 511,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70856,,,883886,[],CHEMBL676422,Antibacterial activity against Escherichia coli 078,F,,,BAO_0002146,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.013
70857,,,883887,[],CHEMBL676423,Antibacterial activity against Escherichia coli 1507E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70858,,,883888,[],CHEMBL772639,Compound was evaluated for antibacterial activity against Pseudomonas aeruginosa 1592E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70859,,,883889,[],CHEMBL772640,Antibacterial activity against Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70860,,,883890,[],CHEMBL798165,Antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.025
70861,,,883891,[],CHEMBL878912,Antibacterial activity against Klebsiella aerogenes 1522E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70862,,,883892,[],CHEMBL673407,Antibacterial activity against Enterobacter cloacae 1321E,F,,,BAO_0002146,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.025
70863,,,883893,[],CHEMBL660610,Compound was evaluated for relative rate of hydrolysis to imipenem by partially purified porcine renal Dehydropeptidase-1,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Percent,67853,=,1,1,=,,Stability,%,,3200.0,CHEMBL2626,Sus scrofa,Renal dipeptidase,9823.0,,,Stability,,UO_0000187,,32.0
70864,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,883894,[],CHEMBL626043,Maximum concentration was calculated.,A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/Nanomolar,67853,=,1,1,=,,Cmax,nM,,19819.02,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,7.6
70865,,,883895,[],CHEMBL635568,Time taken by the compound to reach maximum concentration.,A,,,BAO_0003037,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,67853,=,1,1,=,,Tmax,hr,,0.21,CHEMBL612558,,ADMET,,,,T max,hr,UO_0000032,,0.21
70866,,,883896,[],CHEMBL635239,Half life was calculated.,A,,,BAO_0002115,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,67853,=,1,1,=,,T1/2,hr,,0.24,CHEMBL612558,,ADMET,,,,T1/2,hr,UO_0000032,,0.24
70867,,,883897,[],CHEMBL625188,Area under the curve was calculated for the compound.,A,,,BAO_0002120,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67853,=,1,0,=,,AUC,ug ml-1,,3.29,CHEMBL612558,,ADMET,,,,AUC,ug ml-1,UO_0000274,,3.29
70868,,,883898,[],CHEMBL625188,Area under the curve was calculated for the compound.,A,,,BAO_0002120,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,67853,=,1,0,=,,AUC,hr,,2.0,CHEMBL612558,,ADMET,,,,AUC,hr,UO_0000032,,2.0
70869,,,883899,[],CHEMBL812032,Compound was tested for in vivo protective activity against Streptococcus pyogenes 77A at a single subcutaneous administration in mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,67853,=,1,0,=,,PD50,mg kg-1,,7.16,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,7.16
70870,,,883900,[],CHEMBL678661,Compound was tested for in vivo protective activity against Escherichia coli 078 at a single subcutaneous administration in mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,67853,=,1,0,=,,PD50,mg kg-1,,1.24,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.24
70871,,,883901,[],CHEMBL770918,Compound was tested for in vivo protective activity against Pseudomonas aeruginosa 1771M at a single subcutaneous administration in mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1130853,Bioorg Med Chem Lett,1998.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,67853,=,1,0,=,,PD50,mg kg-1,,1.76,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,1.76
70872,,,887964,[],CHEMBL809190,Minimum inhibitory concentration against Streptococcus pyogenes 308A was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70873,,,887965,[],CHEMBL814220,Minimum inhibitory concentration against Staphylococcus aureus SG 511 was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70874,,,887966,[],CHEMBL814217,Minimum inhibitory concentration against Staphylococcus aureus 285 was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70875,,,887967,[],CHEMBL814218,Minimum inhibitory concentration against Staphylococcus aureus 503 was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70876,,,887968,[],CHEMBL677355,Minimum inhibitory concentration against Escherichia coli 055 was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70877,,,887969,[],CHEMBL677356,Minimum inhibitory concentration against Escherichia coli 1507E was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70878,,,887970,[],CHEMBL764807,Minimum inhibitory concentration against Pseudomonas aeruginosa 9027 was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70879,,,887971,[],CHEMBL764805,Minimum inhibitory concentration against Pseudomonas aeruginosa 1592E was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70880,,,887972,[],CHEMBL764806,Minimum inhibitory concentration against Pseudomonas aeruginosa 1771M was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70881,,,887973,[],CHEMBL801697,Minimum inhibitory concentration against Salmonella Typhimurium was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70882,,,887974,[],CHEMBL703220,Minimum inhibitory concentration against Klebsiella aerogenes 1522E was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70883,,,887975,[],CHEMBL877687,Minimum inhibitory concentration against Enterobacter cloacae 1321E was determined by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,175159,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70884,,,887976,[],CHEMBL664144,Stability to porcine renal DHP-I was determined,F,,,BAO_0000375,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133072,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,175159,=,1,0,=,,Activity,,,1.0,CHEMBL3172,Homo sapiens,Dihydropyrimidine dehydrogenase,9606.0,,,Activity,,,,1.0
70885,,,907566,[],CHEMBL816711,In vitro antibacterial activity against Streptococcus pyogenes 308A by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70886,,,907567,[],CHEMBL805879,In vitro antibacterial activity against Staphylococcus aureus SG 511 by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70887,,,907568,[],CHEMBL805723,In vitro antibacterial activity against Staphylococcus aureus SG 285 by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70888,,,907569,[],CHEMBL805878,In vitro antibacterial activity against Staphylococcus aureus SG 503 by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70889,,,907570,[],CHEMBL680470,In vitro antibacterial activity against Escherichia coli 078 by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70890,,,907571,[],CHEMBL682829,In vitro antibacterial activity against Escherichia coli 1507E by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70891,,,907572,[],CHEMBL770054,In vitro antibacterial activity against Pseudomonas aeruginosa 9027 by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70892,,,907573,[],CHEMBL770997,In vitro antibacterial activity against Pseudomonas aeruginosa 1592E by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70893,,,907574,[],CHEMBL798167,In vitro antibacterial activity against Salmonella Typhimurium by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70894,,,907575,[],CHEMBL703214,In vitro antibacterial activity against Klebsiella aerogenes 1522E by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70895,,,907576,[],CHEMBL673976,In vitro antibacterial activity against Enterobacter cloacae 1321E by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70896,,,907577,[],CHEMBL801852,"In vitro DHP-I stability of the compound, expressed as relative t1/2 of hydrolysis to meropenem by partially purified porcine renal DHP-I",F,,,BAO_0002146,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,1.0
70897,,,907578,[],CHEMBL770052,In vitro antibacterial activity against Pseudomonas aeruginosa 1771M by agar dilution method using Mueller-Hinton,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,48402,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70898,,,907579,[],CHEMBL627900,Half life was determined,A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,48402,=,1,1,=,,T1/2,hr,,0.0665,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,min,UO_0000032,,3.99
70899,,,907580,[],CHEMBL622845,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,48402,=,1,1,=,,AUC,ng.hr.mL-1,,6383.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug min ml-1,,,383.0
70900,,,907581,[],CHEMBL623701,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,A,,,BAO_0002759,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133208,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,48402,=,1,1,=,,CL,mL.min-1.kg-1,,54.16,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,ml min-1 kg-1,,,54.16
70901,,,1045867,[],CHEMBL816712,In vitro antibacterial activity against Streptococcus pyogenes 308A,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70902,,,1045868,[],CHEMBL809745,In vitro antibacterial activity against Staphylococcus aureus SG 511,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70903,,,1045869,[],CHEMBL808635,In vitro antibacterial activity against Staphylococcus aureus 285,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70904,,,1045870,[],CHEMBL808637,In vitro antibacterial activity against Staphylococcus aureus 503,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70905,,,1045871,[],CHEMBL677290,In vitro antibacterial activity against Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70906,,,1045872,[],CHEMBL677291,In vitro antibacterial activity against Escherichia coli 1507E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70907,,,1045873,[],CHEMBL878791,In vitro antibacterial activity against Pseudomonas aeruginosa 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70908,,,1045874,[],CHEMBL770984,In vitro antibacterial activity against Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70909,,,1045875,[],CHEMBL801688,In vitro antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70910,,,1045876,[],CHEMBL703212,In vitro antibacterial activity against Klebsiella aerogenes 1522E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70911,,,1045877,[],CHEMBL676657,In vitro antibacterial activity against Enterobacter cloacae 1321E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141028,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70912,,,1045878,[],CHEMBL843945,DHP-I stability of compound relative to t1/2 of hydrolysis to meropenem,F,,,BAO_0000179,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Percent,141028,=,1,1,=,,Stability,%,,100.0,CHEMBL612545,,Unchecked,,,,Stability,,UO_0000187,,1.0
70913,,,1045879,[],CHEMBL621133,Half life of compound after iv administration of 20 mg/kg dose in rat,A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://qudt.org/vocab/unit#Hour,141028,=,1,1,=,,T1/2,hr,,0.0665,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,min,UO_0000032,,3.99
70914,,,1045880,[],CHEMBL627833,Area under curve of compound after iv administration of 20 mg/kg dose in rat,A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,141028,=,1,1,=,,AUC,ng.hr.mL-1,,6383.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug min ml-1,,,383.0
70915,,,1045881,[],CHEMBL623695,Clearance of compound after iv administration of 20 mg/kg dose in rat,A,,,BAO_0002759,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133947,Bioorg Med Chem Lett,2001.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,141028,=,1,1,=,,CL,mL.min-1.kg-1,,54.16,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,ml min-1 kg-1,,,54.16
70916,,Low activity,1116432,[],CHEMBL764787,Tested for broad spectrum antibacterial activity against Pseudomonas aeruginosa; A - active compound,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1128163,Bioorg Med Chem Lett,1995.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,27916,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
70917,,,1234707,[],CHEMBL805501,Antibacterial activity against Streptococcus pyogenes 308A,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70918,,,1234708,[],CHEMBL809465,Antibacterial activity against Staphylococcus aureus SG 511,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70919,,,1234709,[],CHEMBL809459,Antibacterial activity against Staphylococcus aureus 285,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70920,,,1234710,[],CHEMBL809461,Antibacterial activity against Staphylococcus aureus 503,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
70921,,,1234711,[],CHEMBL675314,Antibacterial activity against Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70922,,,1234712,[],CHEMBL675315,Antibacterial activity against Escherichia coli 1507E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70923,,,1234713,[],CHEMBL770150,Antibacterial activity against Pseudomonas aeruginosa 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70924,,,1234714,[],CHEMBL770148,Antibacterial activity against Pseudomonas aeruginosa 1529E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
70925,,,1234715,[],CHEMBL770149,Antibacterial activity against Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70926,,,1234716,[],CHEMBL803301,Antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70927,,,1234717,[],CHEMBL703388,Antibacterial activity against Klebsiella aerogenes 1522E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70928,,,1234718,[],CHEMBL679039,Antibacterial activity against Enterobacter cloacae 1321E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70929,,,1234719,[],CHEMBL664439,Compound was evaluated for its relative half life of hydrolysis to meropenem by partially purified porcine renal dihydropeptidase-I (DHP-I),F,,,BAO_0002146,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,1.0
70930,,,1234720,[],CHEMBL673716,Compound was evaluated for its antibacterial activity against Escherichia coli DC 0,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70931,,,1234721,[],CHEMBL673717,Compound was evaluated for its antibacterial activity against Escherichia coli DC 2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70932,,,1234722,[],CHEMBL673718,Compound was evaluated for its antibacterial activity against Escherichia coli TEM,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
70933,,,1234723,[],CHEMBL676441,Compound was evaluated for its antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
70934,,,1234724,[],CHEMBL676440,Compound was evaluated for its antibacterial activity against Escherichia coli 0157:H7,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70935,,,1234725,[],CHEMBL676442,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1108 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70936,,,1234726,[],CHEMBL676443,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1109 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70937,,,1234727,[],CHEMBL859386,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1110 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
70938,,,1234728,[],CHEMBL676444,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1111 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
70939,,,1234729,[],CHEMBL676445,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1112 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
70940,,,1234730,[],CHEMBL676446,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1113 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70941,,,1234731,[],CHEMBL676447,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1114 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70942,,,1234732,[],CHEMBL676448,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1115 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
70943,,,1234733,[],CHEMBL673714,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1116 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70944,,,1234734,[],CHEMBL673715,Compound was evaluated for its antibacterial activity against Escherichia coli CCARM 1117 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
70945,,,1234735,[],CHEMBL766464,Compound was evaluated for its antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
70946,,,1234736,[],CHEMBL766462,Compound was evaluated for its antibacterial activity against Pseudomonas aeruginosa 1 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
70947,,,1234737,[],CHEMBL766463,Compound was evaluated for its antibacterial activity against Pseudomonas aeruginosa 2 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
70948,,,1234738,[],CHEMBL879009,Compound was evaluated for its antibacterial activity against Pseudomonas aeruginosa 3 MDR,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
70949,,,1234739,[],CHEMBL803309,Compound was evaluated for its antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
70950,,,1234740,[],CHEMBL803310,Compound was evaluated for its antibacterial activity against Salmonella Typhimurium 1,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
70951,,,1234741,[],CHEMBL803311,Compound was evaluated for its antibacterial activity against Salmonella Typhimurium 2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.016
70952,,,1234742,[],CHEMBL700279,Compound was evaluated for its antibacterial activity against Klebsiella oxytoca 1082E,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.06
70953,,,1234743,[],CHEMBL673414,Compound was evaluated for its antibacterial activity against Enterobacter cloacae P99,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
70954,,,1234744,[],CHEMBL803221,Compound was evaluated for its antibacterial activity against Staphylococcus enteritidis,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.016
70955,,,1234745,[],CHEMBL803222,Compound was evaluated for its antibacterial activity against Staphylococcus enteritidis 1,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.016
70956,,,1234746,[],CHEMBL803223,Compound was evaluated for its antibacterial activity against Staphylococcus enteritidis 2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.016
70957,,,1234747,[],CHEMBL803224,Compound was evaluated for its antibacterial activity against Staphylococcus enteritidis 3,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.03
70958,,,1234748,[],CHEMBL803697,Compound was evaluated for its antibacterial activity against Shigella flexneri ATCC 9199,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,0.03
70959,,,1234749,[],CHEMBL802307,Compound was evaluated for its antibacterial activity against Shigella sonnei ATCC 9290,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.03
70960,,,1234750,[],CHEMBL700310,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 1 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
70961,,,1234751,[],CHEMBL877918,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 2 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
70962,,,1234752,[],CHEMBL700312,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 3 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
70963,,,1234753,[],CHEMBL700313,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 4 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.016
70964,,,1234754,[],CHEMBL700314,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 5 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.016
70965,,,1234755,[],CHEMBL878259,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 6 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
70966,,,1234756,[],CHEMBL873317,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 7 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
70967,,,1234757,[],CHEMBL699935,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 8 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
70968,,,1234758,[],CHEMBL700093,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 9 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
70969,,,1234759,[],CHEMBL700311,Compound was evaluated for its antibacterial activity against Klebsiella pneumoniae 10 ESBL,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1145884,Bioorg Med Chem Lett,2003.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,265631,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.016
70970,,,1287157,[],CHEMBL673669,In vitro minimum inhibitory concentration required against Escherichia coli ATCC 25922 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
70971,,,1287158,[],CHEMBL878418,In vitro minimum inhibitory concentration required against Escherichia coli GC 2205 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
70972,,,1287159,[],CHEMBL673670,In vitro minimum inhibitory concentration required against Escherichia coli GC 1792 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
70973,,,1287160,[],CHEMBL679444,In vitro minimum inhibitory concentration required against Enterobacter cloacae GC 2209 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
70974,,,1287161,[],CHEMBL663433,In vitro minimum inhibitory concentration required against Citrobacter freundii GC 2211 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.06
70975,,,1287162,[],CHEMBL732724,In vitro minimum inhibitory concentration required against Morganella morganii GC 2213 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
70976,,,1287163,[],CHEMBL636113,In vitro minimum inhibitory concentration required against Acinetobacter calcoaceticus GC 756 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.5
70977,,,1287164,[],CHEMBL769411,In vitro minimum inhibitory concentration required against Pseudomonas aeruginosa ATCC 27853 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
70978,,,1287165,[],CHEMBL769412,In vitro minimum inhibitory concentration required against Pseudomonas aeruginosa GC 1544 oprD- strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
70979,,,1287166,[],CHEMBL823322,In vitro minimum inhibitory concentration required against Xanthomonas maltophilia GC 562 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,128.0
70980,,,1287167,[],CHEMBL810764,In vitro minimum inhibitory concentration required against Staphylococcus aureus ATCC 29213 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
70981,,,1287168,[],CHEMBL810996,In vitro minimum inhibitory concentration required against Staphylococcus aureus GC 2220 MRSA strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
70982,,,1287169,[],CHEMBL677619,In vitro minimum inhibitory concentration required against Enterococcus faecalis GC 842 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
70983,,,1287170,[],CHEMBL676718,In vitro minimum inhibitory concentration required against Enterococcus faecium GC 1182 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,74568,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,128.0
70984,,Not Determined,1287171,[],CHEMBL675625,Effective single oral dose required for inhibition of Escherichia coli in mice; Not tested,F,,,BAO_0003036,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,74568,,1,0,,,ED50,mg.kg-1,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,
70985,,Not Determined,1287172,[],CHEMBL675627,Effective single subcutaneous dose required for inhibition of Escherichia coli in mice; Not tested,F,,,BAO_0003036,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,74568,,1,0,,,ED50,mg.kg-1,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,
70986,,,1287173,[],CHEMBL801850,Relative hydrolysis was measured by hog renal dehydropeptidase (DHP).,F,,,BAO_0000179,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1151058,Bioorg Med Chem Lett,1997.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,74568,=,1,0,=,,Relative hydrolysis,,,28.0,CHEMBL612545,,Unchecked,,,,Relative hydrolysis,,,,28.0
70987,,,1292642,[],CHEMBL808961,Compound was evaluated for in vitro antibacterial activity against Streptococcus pyogenes 77A strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.013
70988,,,1292643,[],CHEMBL812910,Compound was evaluated for in vitro antibacterial activity against Streptococcus faecium MD strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,6.25
70989,,,1292644,[],CHEMBL810107,Compound was evaluated for in vitro antibacterial activity against Staphylococcus aureus SG511 strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.013
70990,,,1292645,[],CHEMBL882403,Compound was evaluated for in vitro antibacterial activity against Staphylococcus aureus 285 strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
70991,,,1292646,[],CHEMBL676431,Compound was evaluated for in vitro antibacterial activity against Escherichia coli 078 strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.013
70992,,,1292647,[],CHEMBL676432,Compound was evaluated for in vitro antibacterial activity against Escherichia coli 1507 E strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
70993,,,1292648,[],CHEMBL768167,Compound was evaluated for in vitro antibacterial activity against Pseudomonas aeruginosa 1771 strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.361,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.361
70994,,,1292649,[],CHEMBL858589,Compound was evaluated for in vitro antibacterial activity against Pseudomonas aeruginosa 1771 M strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.049
70995,,,1292650,[],CHEMBL803307,Compound was evaluated for in vitro antibacterial activity against Salmonella Typhimurium by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.049
70996,,,1292651,[],CHEMBL700278,Compound was evaluated for in vitro antibacterial activity against Klebsiella oxytoca 1082 E strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.049
70997,,,1292652,[],CHEMBL703390,Compound was evaluated for in vitro antibacterial activity against Klebsiella aerogenes 1522 E strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.049
70998,,,1292653,[],CHEMBL673411,Compound was evaluated for in vitro antibacterial activity against Enterobacter cloacae P99 strain by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,214190,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
70999,,,1292654,[],CHEMBL664139,Compound was evaluated for DHP-1 stability by using purified porcine renal enzyme,F,,,BAO_0000375,BAO_0000019,assay format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1133391,Bioorg Med Chem Lett,2000.0,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,214190,=,1,0,=,,Activity,,,32.0,CHEMBL2626,Sus scrofa,Renal dipeptidase,9823.0,,,Activity,,,,32.0
